Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/unpaywall/the-role-of-magnetic-resonance-imaging-for-the-diagnosis-of-atypical-0SEzaQO80n
References (284)
-
(PyatigorskayaNGauravRArnaldiDLeu-SemenescuSYahia-CherifLValabregueR. Magnetic resonance imaging biomarkers to assess substantia nigra damage in idiopathic rapid eye movement sleep behavior disorder. Sleep. (2017) 40: 10.1093/sleep/zsx14928958075)
PyatigorskayaNGauravRArnaldiDLeu-SemenescuSYahia-CherifLValabregueR. Magnetic resonance imaging biomarkers to assess substantia nigra damage in idiopathic rapid eye movement sleep behavior disorder. Sleep. (2017) 40: 10.1093/sleep/zsx14928958075PyatigorskayaNGauravRArnaldiDLeu-SemenescuSYahia-CherifLValabregueR. Magnetic resonance imaging biomarkers to assess substantia nigra damage in idiopathic rapid eye movement sleep behavior disorder. Sleep. (2017) 40: 10.1093/sleep/zsx14928958075, PyatigorskayaNGauravRArnaldiDLeu-SemenescuSYahia-CherifLValabregueR. Magnetic resonance imaging biomarkers to assess substantia nigra damage in idiopathic rapid eye movement sleep behavior disorder. Sleep. (2017) 40: 10.1093/sleep/zsx14928958075
-
D. Vaillancourt, M. Spraker, J. Prodoehl, I. Abraham, D. Corcos, X. Zhou, C. Comella, D. Little (2009)
High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson diseaseNeurology, 72
-
(GalleaCEwenczykCDegosBWelterM-LGrabliDLeu-SemenescuS. Pedunculopontine network dysfunction in Parkinson's disease with postural control and sleep disorders. Mov Disord. (2017) 32:693–704. 10.1002/mds.2692328164375)
GalleaCEwenczykCDegosBWelterM-LGrabliDLeu-SemenescuS. Pedunculopontine network dysfunction in Parkinson's disease with postural control and sleep disorders. Mov Disord. (2017) 32:693–704. 10.1002/mds.2692328164375GalleaCEwenczykCDegosBWelterM-LGrabliDLeu-SemenescuS. Pedunculopontine network dysfunction in Parkinson's disease with postural control and sleep disorders. Mov Disord. (2017) 32:693–704. 10.1002/mds.2692328164375, GalleaCEwenczykCDegosBWelterM-LGrabliDLeu-SemenescuS. Pedunculopontine network dysfunction in Parkinson's disease with postural control and sleep disorders. Mov Disord. (2017) 32:693–704. 10.1002/mds.2692328164375
-
N. Pyatigorskaya, M. Mongin, R. Valabrègue, L. Yahia-Cherif, C. Ewenczyk, C. Poupon, Eden Debellemanière, M. Vidailhet, I. Arnulf, S. Lehéricy (2016)
Medulla oblongata damage and cardiac autonomic dysfunction in Parkinson diseaseNeurology, 87
-
(FedericoFSimoneILLuciveroVde MariMGianniniPIlicetoG. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. (1997) 62:239–42. 10.1136/jnnp.62.3.2399069478)
FedericoFSimoneILLuciveroVde MariMGianniniPIlicetoG. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. (1997) 62:239–42. 10.1136/jnnp.62.3.2399069478FedericoFSimoneILLuciveroVde MariMGianniniPIlicetoG. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. (1997) 62:239–42. 10.1136/jnnp.62.3.2399069478, FedericoFSimoneILLuciveroVde MariMGianniniPIlicetoG. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. (1997) 62:239–42. 10.1136/jnnp.62.3.2399069478
-
(PyatigorskayaNMagninBMonginMYahia-CherifLValabregueRArnaldiD. comparative study of MRI biomarkers in the substantia nigra to discriminate idiopathic Parkinson disease. Am J Neuroradiol. (2018) 39:1460–7. 10.3174/ajnr.A570229954816)
PyatigorskayaNMagninBMonginMYahia-CherifLValabregueRArnaldiD. comparative study of MRI biomarkers in the substantia nigra to discriminate idiopathic Parkinson disease. Am J Neuroradiol. (2018) 39:1460–7. 10.3174/ajnr.A570229954816PyatigorskayaNMagninBMonginMYahia-CherifLValabregueRArnaldiD. comparative study of MRI biomarkers in the substantia nigra to discriminate idiopathic Parkinson disease. Am J Neuroradiol. (2018) 39:1460–7. 10.3174/ajnr.A570229954816, PyatigorskayaNMagninBMonginMYahia-CherifLValabregueRArnaldiD. comparative study of MRI biomarkers in the substantia nigra to discriminate idiopathic Parkinson disease. Am J Neuroradiol. (2018) 39:1460–7. 10.3174/ajnr.A570229954816
-
Christopher Way, D. Pettersson, A. Hiller (2018)
The ‘Hot Cross Bun’ Sign Is Not Always Multiple System Atrophy: Etiologies of 11 CasesJournal of Movement Disorders, 12
-
A. Deistung, A. Schäfer, F. Schweser, Uta Biedermann, R. Turner, J. Reichenbach (2013)
Toward in vivo histology: A comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2 ⁎-imaging at ultra-high magnetic field strengthNeuroImage, 65
-
(KashiharaKShinyaTHigakiF. Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD. Intern Med. (2011) 50:1683–7. 10.2169/internalmedicine.50.510121841326)
KashiharaKShinyaTHigakiF. Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD. Intern Med. (2011) 50:1683–7. 10.2169/internalmedicine.50.510121841326KashiharaKShinyaTHigakiF. Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD. Intern Med. (2011) 50:1683–7. 10.2169/internalmedicine.50.510121841326, KashiharaKShinyaTHigakiF. Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD. Intern Med. (2011) 50:1683–7. 10.2169/internalmedicine.50.510121841326
-
G. Rizzo, P. Martinelli, D. Manners, C. Scaglione, C. Tonon, P. Cortelli, E. Malucelli, S. Capellari, C. Testa, Piero Parchi, P. Montagna, B. Barbiroli, R. Lodi (2008)
Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.Brain : a journal of neurology, 131 Pt 10
-
(OhtsukaCSasakiMKonnoKKatoKTakahashiJYamashitaF. Differentiation of early-stage Parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. Parkinsonism Relat Disord. (2014) 20:755–60. 10.1016/j.parkreldis.2014.04.00524768616)
OhtsukaCSasakiMKonnoKKatoKTakahashiJYamashitaF. Differentiation of early-stage Parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. Parkinsonism Relat Disord. (2014) 20:755–60. 10.1016/j.parkreldis.2014.04.00524768616OhtsukaCSasakiMKonnoKKatoKTakahashiJYamashitaF. Differentiation of early-stage Parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. Parkinsonism Relat Disord. (2014) 20:755–60. 10.1016/j.parkreldis.2014.04.00524768616, OhtsukaCSasakiMKonnoKKatoKTakahashiJYamashitaF. Differentiation of early-stage Parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. Parkinsonism Relat Disord. (2014) 20:755–60. 10.1016/j.parkreldis.2014.04.00524768616
-
(PrakashNHagemanNHuaXTogaAWPerlmanSLSalamonN. Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromes. Neuroimage. (2009) 47:T72–81. 10.1016/j.neuroimage.2009.05.01319446636)
PrakashNHagemanNHuaXTogaAWPerlmanSLSalamonN. Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromes. Neuroimage. (2009) 47:T72–81. 10.1016/j.neuroimage.2009.05.01319446636PrakashNHagemanNHuaXTogaAWPerlmanSLSalamonN. Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromes. Neuroimage. (2009) 47:T72–81. 10.1016/j.neuroimage.2009.05.01319446636, PrakashNHagemanNHuaXTogaAWPerlmanSLSalamonN. Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromes. Neuroimage. (2009) 47:T72–81. 10.1016/j.neuroimage.2009.05.01319446636
-
G. Rizzo, S. Zanigni, R. blasi, D. Grasso, D. Martino, R. Savica, G. Logroscino (2016)
Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An UpdateParkinson's Disease, 2016
-
J. Steele, J. Richardson, J. Olszewski (2014)
Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and DementiaSeminars in Neurology, 34
-
K. Seppi, M. Schocke, K. Mair, R. Esterhammer, C. Scherfler, F. Geser, C. Kremser, S. Boesch, W. Jaschke, W. Poewe, G. Wenning (2006)
Progression of putaminal degeneration in multiple system atrophy: A serial diffusion MR studyNeuroImage, 31
-
(NigroSArabiaGAntoniniAWeisLMarcanteATessitoreA Magnetic resonance Parkinsonism index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy. Eur Radiol. (2017) 27:2665–75. 10.1007/s00330-016-4622-x27761709)
NigroSArabiaGAntoniniAWeisLMarcanteATessitoreA Magnetic resonance Parkinsonism index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy. Eur Radiol. (2017) 27:2665–75. 10.1007/s00330-016-4622-x27761709NigroSArabiaGAntoniniAWeisLMarcanteATessitoreA Magnetic resonance Parkinsonism index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy. Eur Radiol. (2017) 27:2665–75. 10.1007/s00330-016-4622-x27761709, NigroSArabiaGAntoniniAWeisLMarcanteATessitoreA Magnetic resonance Parkinsonism index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy. Eur Radiol. (2017) 27:2665–75. 10.1007/s00330-016-4622-x27761709
-
G. Orrú, W. Pettersson-Yeo, A. Marquand, G. Sartori, A. Mechelli (2012)
Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: A critical reviewNeuroscience & Biobehavioral Reviews, 36
-
(CassidyCMZuccaFAGirgisRRBakerSCWeinsteinJJSharpME. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. Proc Natl Acad Sci USA. (2019) 116:5108–17. 10.1073/pnas.180798311630796187)
CassidyCMZuccaFAGirgisRRBakerSCWeinsteinJJSharpME. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. Proc Natl Acad Sci USA. (2019) 116:5108–17. 10.1073/pnas.180798311630796187CassidyCMZuccaFAGirgisRRBakerSCWeinsteinJJSharpME. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. Proc Natl Acad Sci USA. (2019) 116:5108–17. 10.1073/pnas.180798311630796187, CassidyCMZuccaFAGirgisRRBakerSCWeinsteinJJSharpME. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. Proc Natl Acad Sci USA. (2019) 116:5108–17. 10.1073/pnas.180798311630796187
-
Á. Iranzo, E. Tolosa, E. Gelpí, J. Molinuevo, F. Valldeoriola, M. Serradell, R. Sánchez-Valle, I. Vilaseca, F. Lomeña, D. Vilas, A. Lladó, C. Gaig, J. Santamaria (2013)
Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort studyThe Lancet Neurology, 12
-
(2019)
Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multicentre Machine Learning Study–The Lancet Digital Health -
G. Rizzo, M. Copetti, S. Arcuti, D. Martino, A. Fontana, G. Logroscino (2016)
Accuracy of clinical diagnosis of Parkinson diseaseNeurology, 86
-
D. Paviour, S. Price, M. Jahanshahi, A. Lees, Nick Fox (2006)
Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.Brain : a journal of neurology, 129 Pt 4
-
K. Seppi, M. Schocke, Kathrin Prennschuetz-Schuetzenau, K. Mair, R. Esterhammer, C. Kremser, A. Muigg, C. Scherfler, W. Jaschke, G. Wenning, W. Poewe (2006)
Topography of putaminal degeneration in multiple system atrophy: A diffusion magnetic resonance studyMovement Disorders, 21
-
(YuFBarronDSTantiwongkosiBFoxP. Patterns of gray matter atrophy in atypical Parkinsonism syndromes: a VBM meta-analysis. Brain Behav. (2015) 5:e00329. 10.1002/brb3.32926085961)
YuFBarronDSTantiwongkosiBFoxP. Patterns of gray matter atrophy in atypical Parkinsonism syndromes: a VBM meta-analysis. Brain Behav. (2015) 5:e00329. 10.1002/brb3.32926085961YuFBarronDSTantiwongkosiBFoxP. Patterns of gray matter atrophy in atypical Parkinsonism syndromes: a VBM meta-analysis. Brain Behav. (2015) 5:e00329. 10.1002/brb3.32926085961, YuFBarronDSTantiwongkosiBFoxP. Patterns of gray matter atrophy in atypical Parkinsonism syndromes: a VBM meta-analysis. Brain Behav. (2015) 5:e00329. 10.1002/brb3.32926085961
-
N. Pyatigorskaya, R. Gaurav, D. Arnaldi, S. Leu-Semenescu, L. Yahia-Cherif, R. Valabrègue, M. Vidailhet, I. Arnulf, S. Lehéricy (2017)
Magnetic Resonance Imaging Biomarkers to Assess Substantia Nigra Damage in Idiopathic Rapid Eye Movement Sleep Behavior DisorderSLEEP, 40
-
(LehéricySSharmanMADos SantosCLPaquinRGalleaC. Magnetic resonance imaging of the substantia nigra in Parkinson's disease. Mov Disord. (2012) 27:822–30. 10.1002/mds.2501522649063)
LehéricySSharmanMADos SantosCLPaquinRGalleaC. Magnetic resonance imaging of the substantia nigra in Parkinson's disease. Mov Disord. (2012) 27:822–30. 10.1002/mds.2501522649063LehéricySSharmanMADos SantosCLPaquinRGalleaC. Magnetic resonance imaging of the substantia nigra in Parkinson's disease. Mov Disord. (2012) 27:822–30. 10.1002/mds.2501522649063, LehéricySSharmanMADos SantosCLPaquinRGalleaC. Magnetic resonance imaging of the substantia nigra in Parkinson's disease. Mov Disord. (2012) 27:822–30. 10.1002/mds.2501522649063
-
(MorelliMArabiaGNovellinoFSalsoneMGiofrèLCondinoF. MRI measurements predict PSP in unclassifiable Parkinsonisms: a cohort study. Neurology. (2011) 77:1042–7. 10.1212/WNL.0b013e31822e55d021832222)
MorelliMArabiaGNovellinoFSalsoneMGiofrèLCondinoF. MRI measurements predict PSP in unclassifiable Parkinsonisms: a cohort study. Neurology. (2011) 77:1042–7. 10.1212/WNL.0b013e31822e55d021832222MorelliMArabiaGNovellinoFSalsoneMGiofrèLCondinoF. MRI measurements predict PSP in unclassifiable Parkinsonisms: a cohort study. Neurology. (2011) 77:1042–7. 10.1212/WNL.0b013e31822e55d021832222, MorelliMArabiaGNovellinoFSalsoneMGiofrèLCondinoF. MRI measurements predict PSP in unclassifiable Parkinsonisms: a cohort study. Neurology. (2011) 77:1042–7. 10.1212/WNL.0b013e31822e55d021832222
-
L. Kalia, A. Lang (2015)
Parkinson's diseaseThe Lancet, 386
-
G. Nicoletti, G. Rizzo, Gaetano Barbagallo, C. Tonon, F. Condino, D. Manners, D. Messina, C. Testa, G. Arabia, A. Gambardella, R. Lodi, A. Quattrone (2013)
Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.Radiology, 267 3
-
M. Pellecchia, P. Barone, C. Mollica, E. Salvatore, Marta Ianniciello, K. Longo, A. Varrone, Caterina Vicidomini, M. Picillo, G. Michele, A. Filla, M. Salvatore, S. Pappatà (2009)
Diffusion‐weighted imaging in multiple system atrophy: A comparison between clinical subtypesMovement Disorders, 24
-
(SchwarzSTAfzalMMorganPSBajajNGowlandPAAuerDP. The “swallow tail” appearance of the healthy nigrosome–a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T. PLoS ONE. (2014) 9:e93814. 10.1371/journal.pone.009381424710392)
SchwarzSTAfzalMMorganPSBajajNGowlandPAAuerDP. The “swallow tail” appearance of the healthy nigrosome–a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T. PLoS ONE. (2014) 9:e93814. 10.1371/journal.pone.009381424710392SchwarzSTAfzalMMorganPSBajajNGowlandPAAuerDP. The “swallow tail” appearance of the healthy nigrosome–a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T. PLoS ONE. (2014) 9:e93814. 10.1371/journal.pone.009381424710392, SchwarzSTAfzalMMorganPSBajajNGowlandPAAuerDP. The “swallow tail” appearance of the healthy nigrosome–a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T. PLoS ONE. (2014) 9:e93814. 10.1371/journal.pone.009381424710392
-
C. Galléa, C. Ewenczyk, B. Degos, M. Welter, D. Grabli, S. Leu-Semenescu, R. Valabrègue, P. Berroir, L. Yahia-Cherif, E. Bertasi, S. Fernández-Vidal, É. Bardinet, E. Roze, H. Benali, C. Poupon, C. François, I. Arnulf, S. Lehéricy, M. Vidailhet (2017)
Pedunculopontine network dysfunction in Parkinson's disease with postural control and sleep disordersMovement Disorders, 32
-
(ArnulfINeutelDHerlinBGolmardJ-LLeu-SemenescuSCochen de CockV. Sleepiness in idiopathic REM sleep behavior disorder and Parkinson disease. Sleep. (2015) 38:1529–35. 10.5665/sleep.504026085299)
ArnulfINeutelDHerlinBGolmardJ-LLeu-SemenescuSCochen de CockV. Sleepiness in idiopathic REM sleep behavior disorder and Parkinson disease. Sleep. (2015) 38:1529–35. 10.5665/sleep.504026085299ArnulfINeutelDHerlinBGolmardJ-LLeu-SemenescuSCochen de CockV. Sleepiness in idiopathic REM sleep behavior disorder and Parkinson disease. Sleep. (2015) 38:1529–35. 10.5665/sleep.504026085299, ArnulfINeutelDHerlinBGolmardJ-LLeu-SemenescuSCochen de CockV. Sleepiness in idiopathic REM sleep behavior disorder and Parkinson disease. Sleep. (2015) 38:1529–35. 10.5665/sleep.504026085299
-
(CochraneCJEbmeierKP. Diffusion tensor imaging in Parkinsonian syndromes: a systematic review and meta-analysis. Neurology. (2013) 80:857–64. 10.1212/WNL.0b013e318284070c23439701)
CochraneCJEbmeierKP. Diffusion tensor imaging in Parkinsonian syndromes: a systematic review and meta-analysis. Neurology. (2013) 80:857–64. 10.1212/WNL.0b013e318284070c23439701CochraneCJEbmeierKP. Diffusion tensor imaging in Parkinsonian syndromes: a systematic review and meta-analysis. Neurology. (2013) 80:857–64. 10.1212/WNL.0b013e318284070c23439701, CochraneCJEbmeierKP. Diffusion tensor imaging in Parkinsonian syndromes: a systematic review and meta-analysis. Neurology. (2013) 80:857–64. 10.1212/WNL.0b013e318284070c23439701
-
G. Höglinger, G. Respondek, M. Stamelou, C. Kurz, K. Josephs, A. Lang, B. Mollenhauer, U. Müller, C. Nilsson, J. Whitwell, T. Arzberger, E. Englund, E. Gelpí, A. Giese, D. Irwin, W. Meissner, Alexander Pantelyat, A. Rajput, J. Swieten, C. Troakes, A. Antonini, K. Bhatia, Y. Bordelon, Y. Compta, J. Corvol, C. Colosimo, D. Dickson, R. Dodel, L. Ferguson, M. Grossman, J. Kassubek, F. Krismer, J. Levin, S. Lorenzl, H. Morris, P. Nestor, W. Oertel, W. Poewe, G. Rabinovici, J. Rowe, G. Schellenberg, K. Seppi, T. Eimeren, G. Wenning, A. Boxer, L. Golbe, I. Litvan (2017)
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaMovement Disorders, 32
-
(KassubekJ. MRI-based neuroimaging: atypical Parkinsonisms and other movement disorders. Curr Opin Neurol. (2018) 31:425–30. 10.1097/WCO.000000000000057829952835)
KassubekJ. MRI-based neuroimaging: atypical Parkinsonisms and other movement disorders. Curr Opin Neurol. (2018) 31:425–30. 10.1097/WCO.000000000000057829952835KassubekJ. MRI-based neuroimaging: atypical Parkinsonisms and other movement disorders. Curr Opin Neurol. (2018) 31:425–30. 10.1097/WCO.000000000000057829952835, KassubekJ. MRI-based neuroimaging: atypical Parkinsonisms and other movement disorders. Curr Opin Neurol. (2018) 31:425–30. 10.1097/WCO.000000000000057829952835
-
J. Fearnley, A. Lees (1991)
Ageing and Parkinson's disease: substantia nigra regional selectivity.Brain : a journal of neurology, 114 ( Pt 5)
-
(KatoNAraiKHattoriT. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci. (2003) 210:57–60. 10.1016/S0022-510X(03)00014-512736089)
KatoNAraiKHattoriT. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci. (2003) 210:57–60. 10.1016/S0022-510X(03)00014-512736089KatoNAraiKHattoriT. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci. (2003) 210:57–60. 10.1016/S0022-510X(03)00014-512736089, KatoNAraiKHattoriT. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci. (2003) 210:57–60. 10.1016/S0022-510X(03)00014-512736089
-
(AgostaFSarassoEFilippiM. Functional MRI in Atypical Parkinsonisms. Int Rev Neurobiol. (2018) 142:149–73. 10.1016/bs.irn.2018.09.00230409252)
AgostaFSarassoEFilippiM. Functional MRI in Atypical Parkinsonisms. Int Rev Neurobiol. (2018) 142:149–73. 10.1016/bs.irn.2018.09.00230409252AgostaFSarassoEFilippiM. Functional MRI in Atypical Parkinsonisms. Int Rev Neurobiol. (2018) 142:149–73. 10.1016/bs.irn.2018.09.00230409252, AgostaFSarassoEFilippiM. Functional MRI in Atypical Parkinsonisms. Int Rev Neurobiol. (2018) 142:149–73. 10.1016/bs.irn.2018.09.00230409252
-
Cyril Atkinson-Clement, S. Pinto, A. Eusebio, O. Coulon (2017)
Diffusion tensor imaging in Parkinson's disease: Review and meta-analysisNeuroImage : Clinical, 16
-
(SeppiKSchockeMFHPrennschuetz-SchuetzenauKMairKJEsterhammerRKremserC. Topography of putaminal degeneration in multiple system atrophy: a diffusion magnetic resonance study. Mov Disord. (2006) 21:847–52. 10.1002/mds.2084316538620)
SeppiKSchockeMFHPrennschuetz-SchuetzenauKMairKJEsterhammerRKremserC. Topography of putaminal degeneration in multiple system atrophy: a diffusion magnetic resonance study. Mov Disord. (2006) 21:847–52. 10.1002/mds.2084316538620SeppiKSchockeMFHPrennschuetz-SchuetzenauKMairKJEsterhammerRKremserC. Topography of putaminal degeneration in multiple system atrophy: a diffusion magnetic resonance study. Mov Disord. (2006) 21:847–52. 10.1002/mds.2084316538620, SeppiKSchockeMFHPrennschuetz-SchuetzenauKMairKJEsterhammerRKremserC. Topography of putaminal degeneration in multiple system atrophy: a diffusion magnetic resonance study. Mov Disord. (2006) 21:847–52. 10.1002/mds.2084316538620
-
(SeppiKSchockeMFHMairKJEsterhammerRScherflerCGeserF. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Neuroimage. (2006) 31:240–5. 10.1016/j.neuroimage.2005.12.00616443375)
SeppiKSchockeMFHMairKJEsterhammerRScherflerCGeserF. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Neuroimage. (2006) 31:240–5. 10.1016/j.neuroimage.2005.12.00616443375SeppiKSchockeMFHMairKJEsterhammerRScherflerCGeserF. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Neuroimage. (2006) 31:240–5. 10.1016/j.neuroimage.2005.12.00616443375, SeppiKSchockeMFHMairKJEsterhammerRScherflerCGeserF. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Neuroimage. (2006) 31:240–5. 10.1016/j.neuroimage.2005.12.00616443375
-
(FockeNKHelmsGPantelPMScheeweSKnauthMBachmannCG. Differentiation of typical and atypical Parkinson syndromes by quantitative MR imaging. Am J Neuroradiol. (2011) 32:2087–92. 10.3174/ajnr.A286521998102)
FockeNKHelmsGPantelPMScheeweSKnauthMBachmannCG. Differentiation of typical and atypical Parkinson syndromes by quantitative MR imaging. Am J Neuroradiol. (2011) 32:2087–92. 10.3174/ajnr.A286521998102FockeNKHelmsGPantelPMScheeweSKnauthMBachmannCG. Differentiation of typical and atypical Parkinson syndromes by quantitative MR imaging. Am J Neuroradiol. (2011) 32:2087–92. 10.3174/ajnr.A286521998102, FockeNKHelmsGPantelPMScheeweSKnauthMBachmannCG. Differentiation of typical and atypical Parkinson syndromes by quantitative MR imaging. Am J Neuroradiol. (2011) 32:2087–92. 10.3174/ajnr.A286521998102
-
K. Boelmans, B. Holst, M. Hackius, J. Finsterbusch, C. Gerloff, J. Fiehler, A. Münchau (2012)
Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsyMovement Disorders, 27
-
P. Péran, Gaetano Barbagallo, F. Nemmi, M. Sierra, M. Galitzky, A. Traon, P. Payoux, W. Meissner, O. Rascol (2018)
MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophyMovement Disorders, 33
-
(IranzoATolosaEGelpiEMolinuevoJLValldeoriolaFSerradellM. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol. (2013) 12:443–53. 10.1016/S1474-4422(13)70056-523562390)
IranzoATolosaEGelpiEMolinuevoJLValldeoriolaFSerradellM. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol. (2013) 12:443–53. 10.1016/S1474-4422(13)70056-523562390IranzoATolosaEGelpiEMolinuevoJLValldeoriolaFSerradellM. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol. (2013) 12:443–53. 10.1016/S1474-4422(13)70056-523562390, IranzoATolosaEGelpiEMolinuevoJLValldeoriolaFSerradellM. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol. (2013) 12:443–53. 10.1016/S1474-4422(13)70056-523562390
-
(WhitwellJLAvulaRMasterAVemuriPSenjemMLJonesDT. Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord. (2011) 17:599–605. 10.1016/j.parkreldis.2011.05.01321665514)
WhitwellJLAvulaRMasterAVemuriPSenjemMLJonesDT. Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord. (2011) 17:599–605. 10.1016/j.parkreldis.2011.05.01321665514WhitwellJLAvulaRMasterAVemuriPSenjemMLJonesDT. Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord. (2011) 17:599–605. 10.1016/j.parkreldis.2011.05.01321665514, WhitwellJLAvulaRMasterAVemuriPSenjemMLJonesDT. Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord. (2011) 17:599–605. 10.1016/j.parkreldis.2011.05.01321665514
-
D. Dickson, R. Rademakers, M. Hutton (2007)
Progressive Supranuclear Palsy: Pathology and GeneticsBrain Pathology, 17
-
(DicksonDW. Neuropathology of Parkinson disease. Parkinsonism Relat Disord. (2018) 46:S30–3. 10.1016/j.parkreldis.2017.07.03328780180)
DicksonDW. Neuropathology of Parkinson disease. Parkinsonism Relat Disord. (2018) 46:S30–3. 10.1016/j.parkreldis.2017.07.03328780180DicksonDW. Neuropathology of Parkinson disease. Parkinsonism Relat Disord. (2018) 46:S30–3. 10.1016/j.parkreldis.2017.07.03328780180, DicksonDW. Neuropathology of Parkinson disease. Parkinsonism Relat Disord. (2018) 46:S30–3. 10.1016/j.parkreldis.2017.07.03328780180
-
(CherubiniAMorelliMNisticóRSalsoneMArabiaGVastaR. Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsy. Mov Disord. (2014) 29:266–9. 10.1002/mds.2573724323617)
CherubiniAMorelliMNisticóRSalsoneMArabiaGVastaR. Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsy. Mov Disord. (2014) 29:266–9. 10.1002/mds.2573724323617CherubiniAMorelliMNisticóRSalsoneMArabiaGVastaR. Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsy. Mov Disord. (2014) 29:266–9. 10.1002/mds.2573724323617, CherubiniAMorelliMNisticóRSalsoneMArabiaGVastaR. Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsy. Mov Disord. (2014) 29:266–9. 10.1002/mds.2573724323617
-
S. Reimão, P. Lobo, D. Neutel, L. Guedes, M. Coelho, M. Rosa, Pedro Azevedo, Joana Ferreira, D. Abreu, N. Gonçalves, R. Nunes, Jorge Campos, J. Ferreira (2015)
Substantia nigra neuromelanin‐MR imaging differentiates essential tremor from Parkinson's diseaseMovement Disorders, 30
-
(GratwickeJJahanshahiMFoltynieT. Parkinson's disease dementia: a neural networks perspective. Brain. (2015) 138:1454–76. 10.1093/brain/awv10425888551)
GratwickeJJahanshahiMFoltynieT. Parkinson's disease dementia: a neural networks perspective. Brain. (2015) 138:1454–76. 10.1093/brain/awv10425888551GratwickeJJahanshahiMFoltynieT. Parkinson's disease dementia: a neural networks perspective. Brain. (2015) 138:1454–76. 10.1093/brain/awv10425888551, GratwickeJJahanshahiMFoltynieT. Parkinson's disease dementia: a neural networks perspective. Brain. (2015) 138:1454–76. 10.1093/brain/awv10425888551
-
U. Saeed, Jordana Compagnone, R. Aviv, A. Strafella, S. Black, A. Lang, M. Masellis (2017)
Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging conceptsTranslational Neurodegeneration, 6
-
R. Postuma, J. Gagnon, M. Vendette, M. Fantini, J. Massicotte‐Marquez, J. Montplaisir (2009)
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorderNeurology, 72
-
(LongoniGAgostaFKostićVSStojkovićTPaganiEStošić-OpinćalT. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-Parkinsonism, and Parkinson's disease. Mov Disord. (2011) 26:247–55. 10.1002/mds.2329321412831)
LongoniGAgostaFKostićVSStojkovićTPaganiEStošić-OpinćalT. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-Parkinsonism, and Parkinson's disease. Mov Disord. (2011) 26:247–55. 10.1002/mds.2329321412831LongoniGAgostaFKostićVSStojkovićTPaganiEStošić-OpinćalT. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-Parkinsonism, and Parkinson's disease. Mov Disord. (2011) 26:247–55. 10.1002/mds.2329321412831, LongoniGAgostaFKostićVSStojkovićTPaganiEStošić-OpinćalT. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-Parkinsonism, and Parkinson's disease. Mov Disord. (2011) 26:247–55. 10.1002/mds.2329321412831
-
Xiaojun Guan, Min Xuan, Quanquan Gu, Peiyu Huang, Chunlei Liu, Nian Wang, Xiaojun Xu, W. Luo, Minming Zhang (2017)
Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mappingNMR in Biomedicine, 30
-
(ReiterEMuellerCPinterBKrismerFScherflerCEsterhammerR. Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism. Mov Disord. (2015) 30:1068–76. 10.1002/mds.2617125773707)
ReiterEMuellerCPinterBKrismerFScherflerCEsterhammerR. Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism. Mov Disord. (2015) 30:1068–76. 10.1002/mds.2617125773707ReiterEMuellerCPinterBKrismerFScherflerCEsterhammerR. Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism. Mov Disord. (2015) 30:1068–76. 10.1002/mds.2617125773707, ReiterEMuellerCPinterBKrismerFScherflerCEsterhammerR. Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism. Mov Disord. (2015) 30:1068–76. 10.1002/mds.2617125773707
-
D. García-Lorenzo, Clarisse Santos, C. Ewenczyk, S. Leu-Semenescu, C. Galléa, G. Quattrocchi, P. Lobo, C. Poupon, H. Benali, I. Arnulf, M. Vidailhet, S. Lehéricy (2013)
The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s diseaseBrain, 136
-
(OishiKKonishiJMoriSIshiharaHKawamitsuHFujiiM. Reduced fractional anisotropy in early-stage cerebellar variant of multiple system atrophy. J Neuroimaging. (2009) 19:127–31. 10.1111/j.1552-6569.2008.00262.x18498329)
OishiKKonishiJMoriSIshiharaHKawamitsuHFujiiM. Reduced fractional anisotropy in early-stage cerebellar variant of multiple system atrophy. J Neuroimaging. (2009) 19:127–31. 10.1111/j.1552-6569.2008.00262.x18498329OishiKKonishiJMoriSIshiharaHKawamitsuHFujiiM. Reduced fractional anisotropy in early-stage cerebellar variant of multiple system atrophy. J Neuroimaging. (2009) 19:127–31. 10.1111/j.1552-6569.2008.00262.x18498329, OishiKKonishiJMoriSIshiharaHKawamitsuHFujiiM. Reduced fractional anisotropy in early-stage cerebellar variant of multiple system atrophy. J Neuroimaging. (2009) 19:127–31. 10.1111/j.1552-6569.2008.00262.x18498329
-
N. Prakash, Nathan Hageman, X. Hua, A. Toga, S. Perlman, N. Salamon (2009)
Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromesNeuroImage, 47
-
K. Abe, H. Terakawa, M. Takanashi, Yoshiyuki Watanabe, Hisashi Tanaka, N. Fujita, N. Hirabuki, T. Yanagihara (2000)
Proton magnetic resonance spectroscopy of patients with parkinsonismBrain Research Bulletin, 52
-
(Atkinson-ClementCPintoSEusebioACoulonO. Diffusion tensor imaging in Parkinson's disease: review and meta-analysis. Neuroimage Clin. (2017) 16:98–110. 10.1016/j.nicl.2017.07.01128765809)
Atkinson-ClementCPintoSEusebioACoulonO. Diffusion tensor imaging in Parkinson's disease: review and meta-analysis. Neuroimage Clin. (2017) 16:98–110. 10.1016/j.nicl.2017.07.01128765809Atkinson-ClementCPintoSEusebioACoulonO. Diffusion tensor imaging in Parkinson's disease: review and meta-analysis. Neuroimage Clin. (2017) 16:98–110. 10.1016/j.nicl.2017.07.01128765809, Atkinson-ClementCPintoSEusebioACoulonO. Diffusion tensor imaging in Parkinson's disease: review and meta-analysis. Neuroimage Clin. (2017) 16:98–110. 10.1016/j.nicl.2017.07.01128765809
-
I. Litvan, Y. Agid, D. Calne, G. Campbell, B. Dubois, R. Duvoisin, C. Goetz, L. Golbe, J. Grafman, J. Growdon, M. Hallett, J. Jankovic, N. Quinn, E. Tolosa, D. Zee (1996)
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)Neurology, 47
-
(AdachiMKawanamiTOhshimaHSugaiYHosoyaT. Morning glory sign: a particular MR finding in progressive supranuclear palsy. Magn Reson Med Sci. (2004) 3:125–32. 10.2463/mrms.3.12516093629)
AdachiMKawanamiTOhshimaHSugaiYHosoyaT. Morning glory sign: a particular MR finding in progressive supranuclear palsy. Magn Reson Med Sci. (2004) 3:125–32. 10.2463/mrms.3.12516093629AdachiMKawanamiTOhshimaHSugaiYHosoyaT. Morning glory sign: a particular MR finding in progressive supranuclear palsy. Magn Reson Med Sci. (2004) 3:125–32. 10.2463/mrms.3.12516093629, AdachiMKawanamiTOhshimaHSugaiYHosoyaT. Morning glory sign: a particular MR finding in progressive supranuclear palsy. Magn Reson Med Sci. (2004) 3:125–32. 10.2463/mrms.3.12516093629
-
(PellecchiaMTBaronePMollicaCSalvatoreEIannicielloMLongoK. Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. Mov Disord. (2009) 24:689–96. 10.1002/mds.2244019117367)
PellecchiaMTBaronePMollicaCSalvatoreEIannicielloMLongoK. Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. Mov Disord. (2009) 24:689–96. 10.1002/mds.2244019117367PellecchiaMTBaronePMollicaCSalvatoreEIannicielloMLongoK. Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. Mov Disord. (2009) 24:689–96. 10.1002/mds.2244019117367, PellecchiaMTBaronePMollicaCSalvatoreEIannicielloMLongoK. Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. Mov Disord. (2009) 24:689–96. 10.1002/mds.2244019117367
-
(García-LorenzoDLongo-Dos SantosCEwenczykCLeu-SemenescuSGalleaCQuattrocchiG. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease. Brain. (2013) 136:2120–9. 10.1093/brain/awt15223801736)
García-LorenzoDLongo-Dos SantosCEwenczykCLeu-SemenescuSGalleaCQuattrocchiG. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease. Brain. (2013) 136:2120–9. 10.1093/brain/awt15223801736García-LorenzoDLongo-Dos SantosCEwenczykCLeu-SemenescuSGalleaCQuattrocchiG. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease. Brain. (2013) 136:2120–9. 10.1093/brain/awt15223801736, García-LorenzoDLongo-Dos SantosCEwenczykCLeu-SemenescuSGalleaCQuattrocchiG. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease. Brain. (2013) 136:2120–9. 10.1093/brain/awt15223801736
-
Yong-Hee Han, Jae-Hyeok Lee, Bok-man Kang, C. Mun, S. Baik, Y. Shin, Kyu-Hyun Park (2013)
Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophyJournal of the Neurological Sciences, 325
-
Shin-ichiro Kitao, E. Matsusue, S. Fujii, F. Miyoshi, T. Kaminou, S. Kato, Hisao Ito, T. Ogawa (2013)
Correlation between pathology and neuromelanin MR imaging in Parkinson’s disease and dementia with Lewy bodiesNeuroradiology, 55
-
(NicolettiGRizzoGBarbagalloGTononCCondinoFMannersD Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or Parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease. Radiology. (2013) 267:843–50. 10.1148/radiol.1212036423329659)
NicolettiGRizzoGBarbagalloGTononCCondinoFMannersD Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or Parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease. Radiology. (2013) 267:843–50. 10.1148/radiol.1212036423329659NicolettiGRizzoGBarbagalloGTononCCondinoFMannersD Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or Parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease. Radiology. (2013) 267:843–50. 10.1148/radiol.1212036423329659, NicolettiGRizzoGBarbagalloGTononCCondinoFMannersD Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or Parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease. Radiology. (2013) 267:843–50. 10.1148/radiol.1212036423329659
-
M. Adachi, T. Kawanami, H. Ohshima, Y. Sugai, T. Hosoya (2004)
Morning glory sign: a particular MR finding in progressive supranuclear palsy.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine, 3 3
-
S. Schwarz, M. Abaei, V. Gontu, P. Morgan, N. Bajaj, D. Auer (2013)
Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis☆NeuroImage : Clinical, 3
-
P. Mahlknecht, A. Hotter, A. Hussl, R. Esterhammer, M. Schocke, K. Seppi (2010)
Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson’s DiseaseNeurodegenerative Diseases, 7
-
G. Tedeschi, I. Litvan, S. Bonavita, A. Bertolino, N. Lundbom, N. Patronas, M. Hallett (1997)
Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.Brain : a journal of neurology, 120 ( Pt 9)
-
T. Eckert, M. Sailer, J. Kaufmann, C. Schrader, T. Peschel, N. Bodammer, H. Heinze, M. Schoenfeld (2004)
Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imagingNeuroImage, 21
-
(PlanettaPJOforiEPasternakOBurciuRGShuklaPDeSimoneJC. Free-water imaging in Parkinson's disease and atypical Parkinsonism. Brain. (2016) 139:495–508. 10.1093/brain/awv36126705348)
PlanettaPJOforiEPasternakOBurciuRGShuklaPDeSimoneJC. Free-water imaging in Parkinson's disease and atypical Parkinsonism. Brain. (2016) 139:495–508. 10.1093/brain/awv36126705348PlanettaPJOforiEPasternakOBurciuRGShuklaPDeSimoneJC. Free-water imaging in Parkinson's disease and atypical Parkinsonism. Brain. (2016) 139:495–508. 10.1093/brain/awv36126705348, PlanettaPJOforiEPasternakOBurciuRGShuklaPDeSimoneJC. Free-water imaging in Parkinson's disease and atypical Parkinsonism. Brain. (2016) 139:495–508. 10.1093/brain/awv36126705348
-
(HuppertzH-JMöllerLSüdmeyerMHilkerRHattingenEEggerK. Differentiation of neurodegenerative Parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification. Mov Disord. (2016) 31:1506–17. 10.1002/mds.2671527452874)
HuppertzH-JMöllerLSüdmeyerMHilkerRHattingenEEggerK. Differentiation of neurodegenerative Parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification. Mov Disord. (2016) 31:1506–17. 10.1002/mds.2671527452874HuppertzH-JMöllerLSüdmeyerMHilkerRHattingenEEggerK. Differentiation of neurodegenerative Parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification. Mov Disord. (2016) 31:1506–17. 10.1002/mds.2671527452874, HuppertzH-JMöllerLSüdmeyerMHilkerRHattingenEEggerK. Differentiation of neurodegenerative Parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification. Mov Disord. (2016) 31:1506–17. 10.1002/mds.2671527452874
-
(JosephsKADuffyJRStrandEAMachuldaMMSenjemMLMasterAV. Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain. (2012) 135:1522–36. 10.1093/brain/aws03222382356)
JosephsKADuffyJRStrandEAMachuldaMMSenjemMLMasterAV. Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain. (2012) 135:1522–36. 10.1093/brain/aws03222382356JosephsKADuffyJRStrandEAMachuldaMMSenjemMLMasterAV. Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain. (2012) 135:1522–36. 10.1093/brain/aws03222382356, JosephsKADuffyJRStrandEAMachuldaMMSenjemMLMasterAV. Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain. (2012) 135:1522–36. 10.1093/brain/aws03222382356
-
J. Whitwell, Ramesh Avula, Ankit Master, P. Vemuri, M. Senjem, David Jones, C. Jack, K. Josephs (2011)
Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study.Parkinsonism & related disorders, 17 8
-
J. Whitwell, C. Jack, B. Boeve, J. Parisi, J. Ahlskog, D. Drubach, M. Senjem, D. Knopman, R. Petersen, D. Dickson, K. Josephs (2010)
Imaging correlates of pathology in corticobasal syndromeNeurology, 75
-
Anhar Hassan, J. Parisi, K. Josephs (2012)
Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementiaNeurocase, 18
-
R. Postuma, D. Berg, M. Stern, W. Poewe, C. Olanow, W. Oertel, J. Obeso, K. Marek, I. Litvan, A. Lang, G. Halliday, C. Goetz, T. Gasser, B. Dubois, P. Chan, B. Bloem, C. Adler, G. Deuschl (2015)
MDS clinical diagnostic criteria for Parkinson's diseaseMovement Disorders, 30
-
(QuattroneAMorelliMWilliamsDRVescioBArabiaGNigroS. MR Parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-Parkinsonism. Neurology. (2016) 87:1266–73. 10.1212/WNL.000000000000312527558375)
QuattroneAMorelliMWilliamsDRVescioBArabiaGNigroS. MR Parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-Parkinsonism. Neurology. (2016) 87:1266–73. 10.1212/WNL.000000000000312527558375QuattroneAMorelliMWilliamsDRVescioBArabiaGNigroS. MR Parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-Parkinsonism. Neurology. (2016) 87:1266–73. 10.1212/WNL.000000000000312527558375, QuattroneAMorelliMWilliamsDRVescioBArabiaGNigroS. MR Parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-Parkinsonism. Neurology. (2016) 87:1266–73. 10.1212/WNL.000000000000312527558375
-
(BoelmansKHolstBHackiusMFinsterbuschJGerloffCFiehlerJ. Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy. Mov Disord. (2012) 27:421–7. 10.1002/mds.2492622290788)
BoelmansKHolstBHackiusMFinsterbuschJGerloffCFiehlerJ. Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy. Mov Disord. (2012) 27:421–7. 10.1002/mds.2492622290788BoelmansKHolstBHackiusMFinsterbuschJGerloffCFiehlerJ. Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy. Mov Disord. (2012) 27:421–7. 10.1002/mds.2492622290788, BoelmansKHolstBHackiusMFinsterbuschJGerloffCFiehlerJ. Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy. Mov Disord. (2012) 27:421–7. 10.1002/mds.2492622290788
-
M. Pellecchia, P. Barone, Caterina Vicidomini, C. Mollica, E. Salvatore, Marta Ianniciello, R. Liuzzi, K. Longo, M. Picillo, G. Michele, A. Filla, A. Brunetti, M. Salvatore, S. Pappatà (2011)
Progression of striatal and extrastriatal degeneration in multiple system atrophy: A longitudinal diffusion‐weighted MR studyMovement Disorders, 26
-
B. Chen, Guo-guang Fan, W. Sun, X. Shang, S. Shi, S. Wang, G. Lv, C. Wu (2017)
Usefulness of diffusion-tensor MRI in the diagnosis of Parkinson variant of multiple system atrophy and Parkinson's disease: a valuable tool to differentiate between them?Clinical radiology, 72 7
-
Jonathan Schulz, G. Pagano, Juan Bonfante, H. Wilson, M. Politis (2018)
Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s diseaseBrain, 141
-
Edward Ofori, O. Pasternak, P. Planetta, Hong Li, R. Burciu, A. Snyder, S. Lai, M. Okun, D. Vaillancourt (2015)
Longitudinal changes in free-water within the substantia nigra of Parkinson's disease.Brain : a journal of neurology, 138 Pt 8
-
K. Knudsen, T. Fedorova, A. Hansen, M. Sommerauer, M. Otto, K. Svendsen, Adjmal Nahimi, M. Stokholm, N. Pavese, C. Beier, D. Brooks, P. Borghammer (2018)
In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control studyThe Lancet Neurology, 17
-
(MangesiusSHusslAKrismerFMahlknechtPReiterETagwercherS. MR planimetry in neurodegenerative Parkinsonism yields high diagnostic accuracy for PSP. Parkinsonism Relat Disord. (2018) 46:47–55. 10.1016/j.parkreldis.2017.10.02029126761)
MangesiusSHusslAKrismerFMahlknechtPReiterETagwercherS. MR planimetry in neurodegenerative Parkinsonism yields high diagnostic accuracy for PSP. Parkinsonism Relat Disord. (2018) 46:47–55. 10.1016/j.parkreldis.2017.10.02029126761MangesiusSHusslAKrismerFMahlknechtPReiterETagwercherS. MR planimetry in neurodegenerative Parkinsonism yields high diagnostic accuracy for PSP. Parkinsonism Relat Disord. (2018) 46:47–55. 10.1016/j.parkreldis.2017.10.02029126761, MangesiusSHusslAKrismerFMahlknechtPReiterETagwercherS. MR planimetry in neurodegenerative Parkinsonism yields high diagnostic accuracy for PSP. Parkinsonism Relat Disord. (2018) 46:47–55. 10.1016/j.parkreldis.2017.10.02029126761
-
K. Oishi, J. Konishi, S. Mori, Hiroyuki Ishihara, H. Kawamitsu, M. Fujii, F. Kanda (2009)
Reduced Fractional Anisotropy in Early‐Stage Cerebellar Variant of Multiple System AtrophyJournal of Neuroimaging, 19
-
I. Arnulf, D. Neutel, B. Herlin, J. Golmard, S. Leu-Semenescu, V. Cock, M. Vidailhet (2015)
Sleepiness in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease -
K. Kashihara, Takayoshi Shinya, Fumiyo Higaki (2011)
Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD.Internal medicine, 50 16
-
H. Huppertz, L. Möller, M. Südmeyer, R. Hilker, E. Hattingen, K. Egger, F. Amtage, G. Respondek, M. Stamelou, A. Schnitzler, E. Pinkhardt, W. Oertel, S. Knake, J. Kassubek, G. Höglinger (2016)
Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classificationMovement Disorders, 31
-
S. Lehéricy, M. Sharman, Clarisse Santos, Raphaël Paquin, C. Galléa (2012)
Magnetic resonance imaging of the substantia nigra in Parkinson's diseaseMovement Disorders, 27
-
J. Gratwicke, M. Jahanshahi, T. Foltynie (2015)
Parkinson’s disease dementia: a neural networks perspectiveBrain, 138
-
(RizzoGMartinelliPMannersDScaglioneCTononCCortelliP. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain. (2008) 131:2690–700. 10.1093/brain/awn19518819991)
RizzoGMartinelliPMannersDScaglioneCTononCCortelliP. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain. (2008) 131:2690–700. 10.1093/brain/awn19518819991RizzoGMartinelliPMannersDScaglioneCTononCCortelliP. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain. (2008) 131:2690–700. 10.1093/brain/awn19518819991, RizzoGMartinelliPMannersDScaglioneCTononCCortelliP. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain. (2008) 131:2690–700. 10.1093/brain/awn19518819991
-
(OrrùGPettersson-YeoWMarquandAFSartoriGMechelliA. Using support vector machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Neurosci Biobehav Rev. (2012) 36:1140–52. 10.1016/j.neubiorev.2012.01.00422305994)
OrrùGPettersson-YeoWMarquandAFSartoriGMechelliA. Using support vector machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Neurosci Biobehav Rev. (2012) 36:1140–52. 10.1016/j.neubiorev.2012.01.00422305994OrrùGPettersson-YeoWMarquandAFSartoriGMechelliA. Using support vector machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Neurosci Biobehav Rev. (2012) 36:1140–52. 10.1016/j.neubiorev.2012.01.00422305994, OrrùGPettersson-YeoWMarquandAFSartoriGMechelliA. Using support vector machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Neurosci Biobehav Rev. (2012) 36:1140–52. 10.1016/j.neubiorev.2012.01.00422305994
-
H. Oba, A. Yagishita, H. Terada, A. Barkovich, K. Kutomi, T. Yamauchi, S. Furui, T. Shimizu, M. Uchigata, Kiichiro Matsumura, M. Sonoo, M. Sakai, K. Takada, A. Harasawa, K. Takeshita, H. Kohtake, H. Tanaka, S. Suzuki (2005)
New and reliable MRI diagnosis for progressive supranuclear palsyNeurology, 64
-
(PaviourDCPriceSLStevensJMLeesAJFoxNC. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology. (2005) 64:675–9. 10.1212/01.WNL.0000151854.85743.C715728291)
PaviourDCPriceSLStevensJMLeesAJFoxNC. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology. (2005) 64:675–9. 10.1212/01.WNL.0000151854.85743.C715728291PaviourDCPriceSLStevensJMLeesAJFoxNC. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology. (2005) 64:675–9. 10.1212/01.WNL.0000151854.85743.C715728291, PaviourDCPriceSLStevensJMLeesAJFoxNC. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology. (2005) 64:675–9. 10.1212/01.WNL.0000151854.85743.C715728291
-
(EhrmingerMLatimierAPyatigorskayaNGarcia-LorenzoDLeu-SemenescuSVidailhetM. The coeruleus/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder. Brain. (2016) 139:1180–8. 10.1093/brain/aww00626920675)
EhrmingerMLatimierAPyatigorskayaNGarcia-LorenzoDLeu-SemenescuSVidailhetM. The coeruleus/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder. Brain. (2016) 139:1180–8. 10.1093/brain/aww00626920675EhrmingerMLatimierAPyatigorskayaNGarcia-LorenzoDLeu-SemenescuSVidailhetM. The coeruleus/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder. Brain. (2016) 139:1180–8. 10.1093/brain/aww00626920675, EhrmingerMLatimierAPyatigorskayaNGarcia-LorenzoDLeu-SemenescuSVidailhetM. The coeruleus/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder. Brain. (2016) 139:1180–8. 10.1093/brain/aww00626920675
-
(LevinJKurzAArzbergerTGieseAHöglingerGU. The differential diagnosis and treatment of Atypical Parkinsonism. Dtsch Arztebl Int. (2016) 113:61–9. 10.3238/arztebl.2016.006126900156)
LevinJKurzAArzbergerTGieseAHöglingerGU. The differential diagnosis and treatment of Atypical Parkinsonism. Dtsch Arztebl Int. (2016) 113:61–9. 10.3238/arztebl.2016.006126900156LevinJKurzAArzbergerTGieseAHöglingerGU. The differential diagnosis and treatment of Atypical Parkinsonism. Dtsch Arztebl Int. (2016) 113:61–9. 10.3238/arztebl.2016.006126900156, LevinJKurzAArzbergerTGieseAHöglingerGU. The differential diagnosis and treatment of Atypical Parkinsonism. Dtsch Arztebl Int. (2016) 113:61–9. 10.3238/arztebl.2016.006126900156
-
Roberto Marzi, K. Seppi, B. Högl, C. Müller, C. Scherfler, A. Stefani, Á. Iranzo, E. Tolosa, J. Santamaria, E. Gizewski, M. Schocke, Elisabeth Skalla, C. Kremser, W. Poewe (2016)
Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility‐weighted imaging in idiopathic rapid eye movement sleep behavior disorderAnnals of Neurology, 79
-
G. Nicoletti, C. Tonon, R. Lodi, F. Condino, D. Manners, E. Malucelli, M. Morelli, F. Novellino, S. Paglionico, P. Lanza, D. Messina, P. Barone, L. Morgante, M. Zappia, B. Barbiroli, A. Quattrone (2008)
Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's diseaseMovement Disorders, 23
-
S. Lehéricy, A. Hartmann, A. Lannuzel, D. Galanaud, C. Delmaire, Marie-Josée Bienaimée, N. Jodoin, E. Roze, B. Gaymard, M. Vidailhet (2010)
Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.Brain : a journal of neurology, 133 Pt 8
-
S. Schwarz, Mohammed Afzal, P. Morgan, N. Bajaj, P. Gowland, D. Auer (2014)
The ‘Swallow Tail’ Appearance of the Healthy Nigrosome – A New Accurate Test of Parkinson's Disease: A Case-Control and Retrospective Cross-Sectional MRI Study at 3TPLoS ONE, 9
-
Salvatore Nigro, A. Antonini, D. Vaillancourt, K. Seppi, R. Ceravolo, A. Strafella, A. Augimeri, A. Quattrone, M. Morelli, Luca Weis, E. Fiorenzato, R. Biundo, R. Burciu, F. Krismer, Nikolaus McFarland, Christoph Mueller, E. Gizewski, M. Cosottini, E. Prete, S. Mazzucchi, A. Quattrone (2020)
Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort StudyMovement Disorders, 35
-
J. Whitwell, G. Höglinger, A. Antonini, Y. Bordelon, A. Boxer, C. Colosimo, T. Eimeren, L. Golbe, J. Kassubek, C. Kurz, I. Litvan, Alexander Pantelyat, G. Rabinovici, G. Respondek, A. Rominger, J. Rowe, M. Stamelou, K. Josephs (2017)
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Movement Disorders, 32
-
D. Dickson (2018)
Neuropathology of Parkinson disease.Parkinsonism & related disorders, 46 Suppl 1
-
(RizzoGCopettiMArcutiSMartinoDFontanaALogroscinoG. Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology. (2016) 86:566–76. 10.1212/WNL.000000000000235026764028)
RizzoGCopettiMArcutiSMartinoDFontanaALogroscinoG. Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology. (2016) 86:566–76. 10.1212/WNL.000000000000235026764028RizzoGCopettiMArcutiSMartinoDFontanaALogroscinoG. Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology. (2016) 86:566–76. 10.1212/WNL.000000000000235026764028, RizzoGCopettiMArcutiSMartinoDFontanaALogroscinoG. Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology. (2016) 86:566–76. 10.1212/WNL.000000000000235026764028
-
(HöglingerGURespondekGStamelouMKurzCJosephsKALangAE Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. (2017) 32:853–64. 10.1002/mds.26987.28467028)
HöglingerGURespondekGStamelouMKurzCJosephsKALangAE Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. (2017) 32:853–64. 10.1002/mds.26987.28467028HöglingerGURespondekGStamelouMKurzCJosephsKALangAE Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. (2017) 32:853–64. 10.1002/mds.26987.28467028, HöglingerGURespondekGStamelouMKurzCJosephsKALangAE Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. (2017) 32:853–64. 10.1002/mds.26987.28467028
-
(TsukamotoKMatsusueEKanasakiYKakiteSFujiiSKaminouT. Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging. Neuroradiology. (2012) 54:947–55. 10.1007/s00234-012-1009-922274571)
TsukamotoKMatsusueEKanasakiYKakiteSFujiiSKaminouT. Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging. Neuroradiology. (2012) 54:947–55. 10.1007/s00234-012-1009-922274571TsukamotoKMatsusueEKanasakiYKakiteSFujiiSKaminouT. Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging. Neuroradiology. (2012) 54:947–55. 10.1007/s00234-012-1009-922274571, TsukamotoKMatsusueEKanasakiYKakiteSFujiiSKaminouT. Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging. Neuroradiology. (2012) 54:947–55. 10.1007/s00234-012-1009-922274571
-
M. Delgado-Alvarado, B. Gago, I. Navalpotro‐Gómez, Haritz Jiménez-Urbieta, M. Rodriguez-Oroz (2016)
Biomarkers for dementia and mild cognitive impairment in Parkinson's diseaseMovement Disorders, 31
-
D. Paviour, S. Price, J. Stevens, A. Lees, Nick Fox (2005)
Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsyNeurology, 64
-
B. Boeve, M. Silber, C. Saper, T. Ferman, D. Dickson, J. Parisi, E. Benarroch, J. Ahlskog, Glenn Smith, R. Caselli, M. Tippman-Peikert, E. Olson, S.-C. Lin, T. Young, Z. Wszolek, C. Schenck, M. Mahowald, P. Castillo, K. Tredici, H. Braak (2007)
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease.Brain : a journal of neurology, 130 Pt 11
-
J. Barbosa, Antonio Santos, V. Tumas, Manju Liu, Weili Zheng, E. Haacke, C. Salmon (2015)
Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2.Magnetic resonance imaging, 33 5
-
K. Seppi, M. Schocke, R. Esterhammer, C. Kremser, C. Brenneis, Joerg Mueller, S. Boesch, W. Jaschke, W. Poewe, G. Wenning (2003)
Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophyNeurology, 60
-
(SteeleJCRichardsonJCOlszewskiJ. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, Basal Ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Semin Neurol. (2014) 34:129–50. 10.1055/s-0034-137705824963673)
SteeleJCRichardsonJCOlszewskiJ. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, Basal Ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Semin Neurol. (2014) 34:129–50. 10.1055/s-0034-137705824963673SteeleJCRichardsonJCOlszewskiJ. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, Basal Ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Semin Neurol. (2014) 34:129–50. 10.1055/s-0034-137705824963673, SteeleJCRichardsonJCOlszewskiJ. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, Basal Ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Semin Neurol. (2014) 34:129–50. 10.1055/s-0034-137705824963673
-
A. Quattrone, M. Morelli, Salvatore Nigro, A. Quattrone, B. Vescio, G. Arabia, G. Nicoletti, R. Nisticó, M. Salsone, F. Novellino, Gaetano Barbagallo, E. Piane, P. Pugliese, D. Bosco, M. Vaccaro, C. Chiriaco, U. Sabatini, Virginia Vescio, Carlo Stanà, Federico Rocca, Domenico Gullà, M. Caracciolo (2018)
A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.Parkinsonism & related disorders, 54
-
(GuevaraCABlainCRStahlDLythgoeDJLeighPNBarkerGJ. Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Eur J Neurol. (2010) 17:1193–202. 10.1111/j.1468-1331.2010.03010.x20402762)
GuevaraCABlainCRStahlDLythgoeDJLeighPNBarkerGJ. Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Eur J Neurol. (2010) 17:1193–202. 10.1111/j.1468-1331.2010.03010.x20402762GuevaraCABlainCRStahlDLythgoeDJLeighPNBarkerGJ. Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Eur J Neurol. (2010) 17:1193–202. 10.1111/j.1468-1331.2010.03010.x20402762, GuevaraCABlainCRStahlDLythgoeDJLeighPNBarkerGJ. Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Eur J Neurol. (2010) 17:1193–202. 10.1111/j.1468-1331.2010.03010.x20402762
-
Kazumichi Tsukamoto, E. Matsusue, Y. Kanasaki, S. Kakite, S. Fujii, T. Kaminou, T. Ogawa (2012)
Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imagingNeuroradiology, 54
-
(BhattacharyaKSaadiaDEisenkraftBYahrMOlanowWDrayerB. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol. (2002) 59:835–42. 10.1001/archneur.59.5.83512020268)
BhattacharyaKSaadiaDEisenkraftBYahrMOlanowWDrayerB. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol. (2002) 59:835–42. 10.1001/archneur.59.5.83512020268BhattacharyaKSaadiaDEisenkraftBYahrMOlanowWDrayerB. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol. (2002) 59:835–42. 10.1001/archneur.59.5.83512020268, BhattacharyaKSaadiaDEisenkraftBYahrMOlanowWDrayerB. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol. (2002) 59:835–42. 10.1001/archneur.59.5.83512020268
-
(KnudsenKFedorovaTDHansenAKSommerauerMOttoMSvendsenKB. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurol. (2018) 17:618–28. 10.1016/S1474-4422(18)30162-529866443)
KnudsenKFedorovaTDHansenAKSommerauerMOttoMSvendsenKB. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurol. (2018) 17:618–28. 10.1016/S1474-4422(18)30162-529866443KnudsenKFedorovaTDHansenAKSommerauerMOttoMSvendsenKB. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurol. (2018) 17:618–28. 10.1016/S1474-4422(18)30162-529866443, KnudsenKFedorovaTDHansenAKSommerauerMOttoMSvendsenKB. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurol. (2018) 17:618–28. 10.1016/S1474-4422(18)30162-529866443
-
(SalvatoreCCerasaACastiglioniIGallivanoneFAugimeriALopezM. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and progressive Supranuclear palsy. J Neurosci Methods. (2014) 222:230–7. 10.1016/j.jneumeth.2013.11.01624286700)
SalvatoreCCerasaACastiglioniIGallivanoneFAugimeriALopezM. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and progressive Supranuclear palsy. J Neurosci Methods. (2014) 222:230–7. 10.1016/j.jneumeth.2013.11.01624286700SalvatoreCCerasaACastiglioniIGallivanoneFAugimeriALopezM. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and progressive Supranuclear palsy. J Neurosci Methods. (2014) 222:230–7. 10.1016/j.jneumeth.2013.11.01624286700, SalvatoreCCerasaACastiglioniIGallivanoneFAugimeriALopezM. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and progressive Supranuclear palsy. J Neurosci Methods. (2014) 222:230–7. 10.1016/j.jneumeth.2013.11.01624286700
-
(SasakiMShibataETohyamaKTakahashiJOtsukaKTsuchiyaK. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport. (2006) 17:1215–8. 10.1097/01.wnr.0000227984.84927.a716837857)
SasakiMShibataETohyamaKTakahashiJOtsukaKTsuchiyaK. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport. (2006) 17:1215–8. 10.1097/01.wnr.0000227984.84927.a716837857SasakiMShibataETohyamaKTakahashiJOtsukaKTsuchiyaK. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport. (2006) 17:1215–8. 10.1097/01.wnr.0000227984.84927.a716837857, SasakiMShibataETohyamaKTakahashiJOtsukaKTsuchiyaK. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport. (2006) 17:1215–8. 10.1097/01.wnr.0000227984.84927.a716837857
-
(DamierPHirschECAgidYGraybielAM. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain. (1999) 122 (Pt 8):1421–36. 10.1093/brain/122.8.142110430829)
DamierPHirschECAgidYGraybielAM. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain. (1999) 122 (Pt 8):1421–36. 10.1093/brain/122.8.142110430829DamierPHirschECAgidYGraybielAM. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain. (1999) 122 (Pt 8):1421–36. 10.1093/brain/122.8.142110430829, DamierPHirschECAgidYGraybielAM. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain. (1999) 122 (Pt 8):1421–36. 10.1093/brain/122.8.142110430829
-
(BajajSKrismerFPalmaJ-AWenningGKKaufmannHPoeweW. Diffusion-weighted MRI distinguishes Parkinson disease from the Parkinsonian variant of multiple system atrophy: a systematic review and meta-analysis. PLoS ONE. (2017) 12:e0189897. 10.1371/journal.pone.018989729287113)
BajajSKrismerFPalmaJ-AWenningGKKaufmannHPoeweW. Diffusion-weighted MRI distinguishes Parkinson disease from the Parkinsonian variant of multiple system atrophy: a systematic review and meta-analysis. PLoS ONE. (2017) 12:e0189897. 10.1371/journal.pone.018989729287113BajajSKrismerFPalmaJ-AWenningGKKaufmannHPoeweW. Diffusion-weighted MRI distinguishes Parkinson disease from the Parkinsonian variant of multiple system atrophy: a systematic review and meta-analysis. PLoS ONE. (2017) 12:e0189897. 10.1371/journal.pone.018989729287113, BajajSKrismerFPalmaJ-AWenningGKKaufmannHPoeweW. Diffusion-weighted MRI distinguishes Parkinson disease from the Parkinsonian variant of multiple system atrophy: a systematic review and meta-analysis. PLoS ONE. (2017) 12:e0189897. 10.1371/journal.pone.018989729287113
-
L. Möller, J. Kassubek, M. Südmeyer, R. Hilker, E. Hattingen, K. Egger, F. Amtage, E. Pinkhardt, G. Respondek, M. Stamelou, F. Moeller, A. Schnitzler, W. Oertel, S. Knake, H. Huppertz, G. Höglinger (2017)
Manual MRI morphometry in Parkinsonian syndromesMovement Disorders, 32
-
G. Longoni, F. Agosta, V. Kostic, T. Stojković, E. Pagani, T. Stošić‐Opinćal, M. Filippi (2011)
MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy‐parkinsonism, and Parkinson's diseaseMovement Disorders, 26
-
X. Du, X. Lewis, X. Kanekar, X. Sterling, X. He, X. Kong, X. Li, X. Huang, M. Du, MD Huang (2017)
ParkinsonismDifferentiate Parkinson Disease and Atypical Apparent Transverse Relaxation Rate Combined Diffusion Tensor Imaging and -
(BoeveBFSilberMHSaperCBFermanTJDicksonDWParisiJE. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. (2007) 130:2770–88. 10.1093/brain/awm05617412731)
BoeveBFSilberMHSaperCBFermanTJDicksonDWParisiJE. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. (2007) 130:2770–88. 10.1093/brain/awm05617412731BoeveBFSilberMHSaperCBFermanTJDicksonDWParisiJE. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. (2007) 130:2770–88. 10.1093/brain/awm05617412731, BoeveBFSilberMHSaperCBFermanTJDicksonDWParisiJE. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. (2007) 130:2770–88. 10.1093/brain/awm05617412731
-
P. Planetta, Edward Ofori, O. Pasternak, R. Burciu, Priyank Shukla, J. DeSimone, M. Okun, Nikolaus McFarland, D. Vaillancourt (2016)
Free-water imaging in Parkinson's disease and atypical parkinsonism.Brain : a journal of neurology, 139 Pt 2
-
(MessinaDCerasaACondinoFArabiaGNovellinoFNicolettiG. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat Disord. (2011) 17:172–6. 10.1016/j.parkreldis.2010.12.01021236720)
MessinaDCerasaACondinoFArabiaGNovellinoFNicolettiG. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat Disord. (2011) 17:172–6. 10.1016/j.parkreldis.2010.12.01021236720MessinaDCerasaACondinoFArabiaGNovellinoFNicolettiG. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat Disord. (2011) 17:172–6. 10.1016/j.parkreldis.2010.12.01021236720, MessinaDCerasaACondinoFArabiaGNovellinoFNicolettiG. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat Disord. (2011) 17:172–6. 10.1016/j.parkreldis.2010.12.01021236720
-
(ZanigniSEvangelistiSTestaCMannersDNCalandra-BuonauraGGuarinoM. White matter and cortical changes in atypical Parkinsonisms: a multimodal quantitative MR study. Parkinsonism Relat Disord. (2017) 39:44–51. 10.1016/j.parkreldis.2017.03.00128291592)
ZanigniSEvangelistiSTestaCMannersDNCalandra-BuonauraGGuarinoM. White matter and cortical changes in atypical Parkinsonisms: a multimodal quantitative MR study. Parkinsonism Relat Disord. (2017) 39:44–51. 10.1016/j.parkreldis.2017.03.00128291592ZanigniSEvangelistiSTestaCMannersDNCalandra-BuonauraGGuarinoM. White matter and cortical changes in atypical Parkinsonisms: a multimodal quantitative MR study. Parkinsonism Relat Disord. (2017) 39:44–51. 10.1016/j.parkreldis.2017.03.00128291592, ZanigniSEvangelistiSTestaCMannersDNCalandra-BuonauraGGuarinoM. White matter and cortical changes in atypical Parkinsonisms: a multimodal quantitative MR study. Parkinsonism Relat Disord. (2017) 39:44–51. 10.1016/j.parkreldis.2017.03.00128291592
-
(Martin-BastidaAPietracupaSPicciniP. Neuromelanin in Parkinsonian disorders: an update. Int J Neurosci. (2017) 127:1116–23. 10.1080/00207454.2017.132588328460588)
Martin-BastidaAPietracupaSPicciniP. Neuromelanin in Parkinsonian disorders: an update. Int J Neurosci. (2017) 127:1116–23. 10.1080/00207454.2017.132588328460588Martin-BastidaAPietracupaSPicciniP. Neuromelanin in Parkinsonian disorders: an update. Int J Neurosci. (2017) 127:1116–23. 10.1080/00207454.2017.132588328460588, Martin-BastidaAPietracupaSPicciniP. Neuromelanin in Parkinsonian disorders: an update. Int J Neurosci. (2017) 127:1116–23. 10.1080/00207454.2017.132588328460588
-
(WatanabeHFukatsuHKatsunoMSugiuraMHamadaKOkadaY. Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. J Neurol Neurosurg Psychiatry. (2004) 75:103–9.14707317)
WatanabeHFukatsuHKatsunoMSugiuraMHamadaKOkadaY. Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. J Neurol Neurosurg Psychiatry. (2004) 75:103–9.14707317WatanabeHFukatsuHKatsunoMSugiuraMHamadaKOkadaY. Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. J Neurol Neurosurg Psychiatry. (2004) 75:103–9.14707317, WatanabeHFukatsuHKatsunoMSugiuraMHamadaKOkadaY. Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. J Neurol Neurosurg Psychiatry. (2004) 75:103–9.14707317
-
(SchulzJPaganoGFernández BonfanteJAWilsonHPolitisM. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease. Brain. (2018) 141:1501–16. 10.1093/brain/awy07229701787)
SchulzJPaganoGFernández BonfanteJAWilsonHPolitisM. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease. Brain. (2018) 141:1501–16. 10.1093/brain/awy07229701787SchulzJPaganoGFernández BonfanteJAWilsonHPolitisM. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease. Brain. (2018) 141:1501–16. 10.1093/brain/awy07229701787, SchulzJPaganoGFernández BonfanteJAWilsonHPolitisM. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease. Brain. (2018) 141:1501–16. 10.1093/brain/awy07229701787
-
(WhitwellJLDuffyJRStrandEAMachuldaMMSenjemMLGunterJL. Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy. Eur J Neurol. (2013) 20:629–37. 10.1111/ene.1200423078273)
WhitwellJLDuffyJRStrandEAMachuldaMMSenjemMLGunterJL. Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy. Eur J Neurol. (2013) 20:629–37. 10.1111/ene.1200423078273WhitwellJLDuffyJRStrandEAMachuldaMMSenjemMLGunterJL. Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy. Eur J Neurol. (2013) 20:629–37. 10.1111/ene.1200423078273, WhitwellJLDuffyJRStrandEAMachuldaMMSenjemMLGunterJL. Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy. Eur J Neurol. (2013) 20:629–37. 10.1111/ene.1200423078273
-
Gaetano Barbagallo, M. Sierra-Peña, F. Nemmi, A. Traon, W. Meissner, O. Rascol, P. Péran (2016)
Multimodal MRI assessment of nigro‐striatal pathway in multiple system atrophy and Parkinson diseaseMovement Disorders, 31
-
A. Deistung, F. Schweser, J. Reichenbach (2017)
Overview of quantitative susceptibility mappingNMR in Biomedicine, 30
-
K. Bhattacharya, D. Saadia, B. Eisenkraft, M. Yahr, W. Olanow, B. Drayer, H. Kaufmann (2002)
Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm.Archives of neurology, 59 5
-
G. Nicoletti, R. Lodi, F. Condino, C. Tonon, F. Fera, E. Malucelli, D. Manners, M. Zappia, L. Morgante, P. Barone, B. Barbiroli, A. Quattrone (2006)
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.Brain : a journal of neurology, 129 Pt 10
-
(TedeschiGLitvanIBonavitaSBertolinoALundbomNPatronasNJ. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain. (1997) 120 (Pt 9):1541–52. 10.1093/brain/120.9.15419313638)
TedeschiGLitvanIBonavitaSBertolinoALundbomNPatronasNJ. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain. (1997) 120 (Pt 9):1541–52. 10.1093/brain/120.9.15419313638TedeschiGLitvanIBonavitaSBertolinoALundbomNPatronasNJ. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain. (1997) 120 (Pt 9):1541–52. 10.1093/brain/120.9.15419313638, TedeschiGLitvanIBonavitaSBertolinoALundbomNPatronasNJ. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain. (1997) 120 (Pt 9):1541–52. 10.1093/brain/120.9.15419313638
-
H. Braak, K. Tredici, U. Rüb, R. Vos, Ernst Steur, E. Braak (2003)
Staging of brain pathology related to sporadic Parkinson’s diseaseNeurobiology of Aging, 24
-
B. Heim, F. Krismer, K. Seppi (2018)
Structural Imaging in Atypical Parkinsonism.International review of neurobiology, 142
-
(CastellaniR. Multiple system atrophy. Am J Pathol. (1998) 153:671–6. 10.1016/S0002-9440(10)65608-89736015)
CastellaniR. Multiple system atrophy. Am J Pathol. (1998) 153:671–6. 10.1016/S0002-9440(10)65608-89736015CastellaniR. Multiple system atrophy. Am J Pathol. (1998) 153:671–6. 10.1016/S0002-9440(10)65608-89736015, CastellaniR. Multiple system atrophy. Am J Pathol. (1998) 153:671–6. 10.1016/S0002-9440(10)65608-89736015
-
(BraakHDel TrediciKRübUde VosRAIJansen SteurENHBraakE. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. (2003) 24:197–11. 10.1016/S0197-4580(02)00065-912498954)
BraakHDel TrediciKRübUde VosRAIJansen SteurENHBraakE. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. (2003) 24:197–11. 10.1016/S0197-4580(02)00065-912498954BraakHDel TrediciKRübUde VosRAIJansen SteurENHBraakE. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. (2003) 24:197–11. 10.1016/S0197-4580(02)00065-912498954, BraakHDel TrediciKRübUde VosRAIJansen SteurENHBraakE. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. (2003) 24:197–11. 10.1016/S0197-4580(02)00065-912498954
-
A. Worker, Camilla Blain, J. Jarosz, K. Chaudhuri, G. Barker, Steven Williams, Richard Brown, P. Leigh, A. Simmons (2014)
Cortical Thickness, Surface Area and Volume Measures in Parkinson's Disease, Multiple System Atrophy and Progressive Supranuclear PalsyPLoS ONE, 9
-
(QuattroneAMorelliMQuattroneAVescioBNigroSArabiaG. Magnetic resonance Parkinsonism index for evaluating disease progression rate in progressive supranuclear palsy: a longitudinal 2-year study. Parkinsonism Relat Disord. (2020) 72:1–6. 10.1016/j.parkreldis.2020.01.01932036297)
QuattroneAMorelliMQuattroneAVescioBNigroSArabiaG. Magnetic resonance Parkinsonism index for evaluating disease progression rate in progressive supranuclear palsy: a longitudinal 2-year study. Parkinsonism Relat Disord. (2020) 72:1–6. 10.1016/j.parkreldis.2020.01.01932036297QuattroneAMorelliMQuattroneAVescioBNigroSArabiaG. Magnetic resonance Parkinsonism index for evaluating disease progression rate in progressive supranuclear palsy: a longitudinal 2-year study. Parkinsonism Relat Disord. (2020) 72:1–6. 10.1016/j.parkreldis.2020.01.01932036297, QuattroneAMorelliMQuattroneAVescioBNigroSArabiaG. Magnetic resonance Parkinsonism index for evaluating disease progression rate in progressive supranuclear palsy: a longitudinal 2-year study. Parkinsonism Relat Disord. (2020) 72:1–6. 10.1016/j.parkreldis.2020.01.01932036297
-
Mickael Ehrminger, Alice Latimier, N. Pyatigorskaya, D. García-Lorenzo, S. Leu-Semenescu, M. Vidailhet, S. Lehéricy, I. Arnulf (2016)
The coeruleus/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder.Brain : a journal of neurology, 139 Pt 4
-
M. Schocke, K. Seppi, R. Esterhammer, C. Kremser, K. Mair, B. Czermak, W. Jaschke, W. Poewe, G. Wenning (2004)
Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's diseaseNeuroImage, 21
-
A. Quattrone, M. Morelli, David Williams, B. Vescio, G. Arabia, Salvatore Nigro, G. Nicoletti, M. Salsone, F. Novellino, R. Nisticó, F. Pucci, C. Chiriaco, P. Pugliese, D. Bosco, M. Caracciolo (2016)
MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP–parkinsonismNeurology, 87
-
H. Kataoka, Y. Nishimori, T. Kiriyama, H. Nanaura, T. Izumi, N. Eura, N. Iwasa, K. Sugie (2019)
Increased Signal in the Superior Cerebellar Peduncle of Patients with Progressive Supranuclear PalsyJournal of Movement Disorders, 12
-
K. Tredici, H. Braak (2016)
Review: Sporadic Parkinson's disease: development and distribution of α‐synuclein pathologyNeuropathology and Applied Neurobiology, 42
-
M. Santos-Santos, M. Santos-Santos, M. Mandelli, Richard Binney, J. Ogar, Stephen Wilson, M. Henry, H. Hubbard, M. Meese, S. Attygalle, L. Rosenberg, M. Pakvasa, J. Trojanowski, L. Grinberg, H. Rosen, A. Boxer, B. Miller, W. Seeley, M. Gorno-Tempini (2016)
Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.JAMA neurology, 73 6
-
A. Cherubini, M. Morelli, R. Nisticó, M. Salsone, G. Arabia, R. Vasta, A. Augimeri, M. Caligiuri, A. Quattrone (2014)
Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsyMovement Disorders, 29
-
F. Agosta, V. Kostic, S. Galantucci, S. Mesaros, M. Svetel, E. Pagani, E. Stefanova, M. Filippi (2010)
The in vivo distribution of brain tissue loss in Richardson’s syndrome and PSP‐parkinsonism: a VBM‐DARTEL studyEuropean Journal of Neuroscience, 32
-
D. Sulzer, C. Cassidy, Guillermo Horga, U. Kang, S. Fahn, L. Casella, G. Pezzoli, J. Langley, Xiaoping Hu, F. Zucca, I. Isaias, L. Zecca (2018)
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s diseaseNPJ Parkinson's Disease, 4
-
P. Mahlknecht, F. Krismer, W. Poewe, K. Seppi (2017)
Meta‐analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's diseaseMovement Disorders, 32
-
A. Quattrone, M. Morelli, A. Quattrone, B. Vescio, Salvatore Nigro, G. Arabia, R. Nisticó, F. Novellino, M. Salsone, P. Arcuri, A. Luca, Alessandro Mazzuca, C. Alessio, Federico Rocca, M. Caracciolo (2020)
Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study.Parkinsonism & related disorders, 72
-
(SeppiKSchockeMFHEsterhammerRKremserCBrenneisCMuellerJ Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the Parkinson variant of multiple system atrophy. Neurology. (2003) 60:922–7. 10.1212/01.WNL.0000049911.91657.9D12654954)
SeppiKSchockeMFHEsterhammerRKremserCBrenneisCMuellerJ Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the Parkinson variant of multiple system atrophy. Neurology. (2003) 60:922–7. 10.1212/01.WNL.0000049911.91657.9D12654954SeppiKSchockeMFHEsterhammerRKremserCBrenneisCMuellerJ Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the Parkinson variant of multiple system atrophy. Neurology. (2003) 60:922–7. 10.1212/01.WNL.0000049911.91657.9D12654954, SeppiKSchockeMFHEsterhammerRKremserCBrenneisCMuellerJ Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the Parkinson variant of multiple system atrophy. Neurology. (2003) 60:922–7. 10.1212/01.WNL.0000049911.91657.9D12654954
-
Fang Yu, D. Barron, B. Tantiwongkosi, P. Fox (2015)
Patterns of gray matter atrophy in atypical parkinsonism syndromes: a VBM meta-analysisBrain and Behavior, 5
-
C. Ohtsuka, M. Sasaki, K. Konno, Kanako Kato, J. Takahashi, F. Yamashita, Y. Terayama (2014)
Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging.Parkinsonism & related disorders, 20 7
-
Hirohisa Watanabe, H. Fukatsu, M. Katsuno, M. Sugiura, K. Hamada, Y. Okada, M. Hirayama, T. Ishigaki, G. Sobue (2004)
Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker.Journal of neurology, neurosurgery, and psychiatry, 75 1
-
(BarbagalloGSierra-PeñaMNemmiFTraonAP-LMeissnerWGRascolO. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease. Mov Disord. (2016) 31:325–34. 10.1002/mds.2647126676922)
BarbagalloGSierra-PeñaMNemmiFTraonAP-LMeissnerWGRascolO. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease. Mov Disord. (2016) 31:325–34. 10.1002/mds.2647126676922BarbagalloGSierra-PeñaMNemmiFTraonAP-LMeissnerWGRascolO. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease. Mov Disord. (2016) 31:325–34. 10.1002/mds.2647126676922, BarbagalloGSierra-PeñaMNemmiFTraonAP-LMeissnerWGRascolO. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease. Mov Disord. (2016) 31:325–34. 10.1002/mds.2647126676922
-
Jae-Hyeok Lee, Yong-Hee Han, Bok-man Kang, C. Mun, Sang-Jae Lee, S. Baik (2013)
Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophyJournal of Neurology, 260
-
Hirohisa Watanabe, Mizuki Ito, H. Fukatsu, J. Senda, N. Atsuta, Tomotsugu Kaga, Shigetaka Kato, M. Katsuno, F. Tanaka, M. Hirayama, S. Naganawa, G. Sobue (2010)
Putaminal magnetic resonance imaging features at various magnetic field strengths in multiple system atrophyMovement Disorders, 25
-
(AbeKTerakawaHTakanashiMWatanabeYTanakaHFujitaN. Proton magnetic resonance spectroscopy of patients with Parkinsonism. Brain Res Bull. (2000) 52:589–95. 10.1016/S0361-9230(00)00321-X10974501)
AbeKTerakawaHTakanashiMWatanabeYTanakaHFujitaN. Proton magnetic resonance spectroscopy of patients with Parkinsonism. Brain Res Bull. (2000) 52:589–95. 10.1016/S0361-9230(00)00321-X10974501AbeKTerakawaHTakanashiMWatanabeYTanakaHFujitaN. Proton magnetic resonance spectroscopy of patients with Parkinsonism. Brain Res Bull. (2000) 52:589–95. 10.1016/S0361-9230(00)00321-X10974501, AbeKTerakawaHTakanashiMWatanabeYTanakaHFujitaN. Proton magnetic resonance spectroscopy of patients with Parkinsonism. Brain Res Bull. (2000) 52:589–95. 10.1016/S0361-9230(00)00321-X10974501
-
J. Kassubek (2018)
MRI-based neuroimaging: atypical parkinsonisms and other movement disordersCurrent Opinion in Neurology, 31
-
A. Quattrone, G. Nicoletti, D. Messina, F. Fera, F. Condino, P. Pugliese, P. Lanza, P. Barone, L. Morgante, M. Zappia, U. Aguglia, O. Gallo (2008)
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.Radiology, 246 1
-
(PyatigorskayaNYahia-CherifLGauravREwenczykCGalleaCValabregueR. Multimodal magnetic resonance imaging quantification of brain changes in progressive Supranuclear palsy. Mov Disord. (2020) 35:161–70. 10.1002/mds.2787731710146)
PyatigorskayaNYahia-CherifLGauravREwenczykCGalleaCValabregueR. Multimodal magnetic resonance imaging quantification of brain changes in progressive Supranuclear palsy. Mov Disord. (2020) 35:161–70. 10.1002/mds.2787731710146PyatigorskayaNYahia-CherifLGauravREwenczykCGalleaCValabregueR. Multimodal magnetic resonance imaging quantification of brain changes in progressive Supranuclear palsy. Mov Disord. (2020) 35:161–70. 10.1002/mds.2787731710146, PyatigorskayaNYahia-CherifLGauravREwenczykCGalleaCValabregueR. Multimodal magnetic resonance imaging quantification of brain changes in progressive Supranuclear palsy. Mov Disord. (2020) 35:161–70. 10.1002/mds.2787731710146
-
N. Pyatigorskaya, L. Yahia-Cherif, R. Gaurav, C. Ewenczyk, C. Galléa, R. Valabrègue, F. Gargouri, B. Magnin, B. Degos, E. Roze, É. Bardinet, C. Poupon, I. Arnulf, M. Vidailhet, S. Lehéricy (2019)
Multimodal Magnetic Resonance Imaging Quantification of Brain Changes in Progressive Supranuclear PalsyMovement Disorders, 35
-
Salvatore Nigro, G. Arabia, A. Antonini, Luca Weis, A. Marcante, A. Tessitore, M. Cirillo, G. Tedeschi, S. Zanigni, G. Calandra-Buonaura, C. Tonon, G. Pezzoli, R. Cilia, M. Zappia, A. Nicoletti, C. Cicero, M. Tinazzi, P. Tocco, N. Cardobi, A. Quattrone (2017)
Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsyEuropean Radiology, 27
-
(PellecchiaMTBaronePVicidominiCMollicaCSalvatoreEIannicielloM. Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. Mov Disord. (2011) 26:1303–9. 10.1002/mds.2360121469200)
PellecchiaMTBaronePVicidominiCMollicaCSalvatoreEIannicielloM. Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. Mov Disord. (2011) 26:1303–9. 10.1002/mds.2360121469200PellecchiaMTBaronePVicidominiCMollicaCSalvatoreEIannicielloM. Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. Mov Disord. (2011) 26:1303–9. 10.1002/mds.2360121469200, PellecchiaMTBaronePVicidominiCMollicaCSalvatoreEIannicielloM. Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. Mov Disord. (2011) 26:1303–9. 10.1002/mds.2360121469200
-
C. Scherfler, G. Göbel, C. Müller, M. Nocker, G. Wenning, M. Schocke, W. Poewe, K. Seppi (2016)
Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonismNeurology, 86
-
(LitvanIAgidYCalneDCampbellGDuboisBDuvoisinRC. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. (1996) 47:1–9. 10.1212/WNL.47.1.18710059)
LitvanIAgidYCalneDCampbellGDuboisBDuvoisinRC. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. (1996) 47:1–9. 10.1212/WNL.47.1.18710059LitvanIAgidYCalneDCampbellGDuboisBDuvoisinRC. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. (1996) 47:1–9. 10.1212/WNL.47.1.18710059, LitvanIAgidYCalneDCampbellGDuboisBDuvoisinRC. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. (1996) 47:1–9. 10.1212/WNL.47.1.18710059
-
N. Pyatigorskaya, B. Magnin, Marie Mongin, L. Yahia-Cherif, R. Valabrègue, Dario Arnaldi, C. Ewenczyk, Cyril Poupon, M. Vidailhet, S. Lehéricy (2018)
Comparative Study of MRI Biomarkers in the Substantia Nigra to Discriminate Idiopathic Parkinson DiseaseAmerican Journal of Neuroradiology, 39
-
(DicksonDWRademakersRHuttonML Progressive supranuclear palsy: pathology and genetics. Brain Pathol. (2007) 17:74–82. 10.1111/j.1750-3639.2007.00054.x17493041)
DicksonDWRademakersRHuttonML Progressive supranuclear palsy: pathology and genetics. Brain Pathol. (2007) 17:74–82. 10.1111/j.1750-3639.2007.00054.x17493041DicksonDWRademakersRHuttonML Progressive supranuclear palsy: pathology and genetics. Brain Pathol. (2007) 17:74–82. 10.1111/j.1750-3639.2007.00054.x17493041, DicksonDWRademakersRHuttonML Progressive supranuclear palsy: pathology and genetics. Brain Pathol. (2007) 17:74–82. 10.1111/j.1750-3639.2007.00054.x17493041
-
(WhitwellJLJackCRParisiJEGunterJLWeigandSDBoeveBF Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur J Neurol. (2013) 20:1417–22. 10.1111/ene.1221223746093)
WhitwellJLJackCRParisiJEGunterJLWeigandSDBoeveBF Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur J Neurol. (2013) 20:1417–22. 10.1111/ene.1221223746093WhitwellJLJackCRParisiJEGunterJLWeigandSDBoeveBF Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur J Neurol. (2013) 20:1417–22. 10.1111/ene.1221223746093, WhitwellJLJackCRParisiJEGunterJLWeigandSDBoeveBF Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur J Neurol. (2013) 20:1417–22. 10.1111/ene.1221223746093
-
(ChenBFanGSunWShangXShiSWangS. Usefulness of diffusion-tensor MRI in the diagnosis of Parkinson variant of multiple system atrophy and Parkinson's disease: a valuable tool to differentiate between them? Clin Radiol. (2017) 72:610.e9–15. 10.1016/j.crad.2017.02.00528318507)
ChenBFanGSunWShangXShiSWangS. Usefulness of diffusion-tensor MRI in the diagnosis of Parkinson variant of multiple system atrophy and Parkinson's disease: a valuable tool to differentiate between them? Clin Radiol. (2017) 72:610.e9–15. 10.1016/j.crad.2017.02.00528318507ChenBFanGSunWShangXShiSWangS. Usefulness of diffusion-tensor MRI in the diagnosis of Parkinson variant of multiple system atrophy and Parkinson's disease: a valuable tool to differentiate between them? Clin Radiol. (2017) 72:610.e9–15. 10.1016/j.crad.2017.02.00528318507, ChenBFanGSunWShangXShiSWangS. Usefulness of diffusion-tensor MRI in the diagnosis of Parkinson variant of multiple system atrophy and Parkinson's disease: a valuable tool to differentiate between them? Clin Radiol. (2017) 72:610.e9–15. 10.1016/j.crad.2017.02.00528318507
-
(LehericySBensimonGVidailhetM Parkinsonian syndromes. In: TogaAW editor. Brain Mapping (Waltham: Academic Press), 769–85. 10.1016/B978-0-12-397025-1.00088-9)
LehericySBensimonGVidailhetM Parkinsonian syndromes. In: TogaAW editor. Brain Mapping (Waltham: Academic Press), 769–85. 10.1016/B978-0-12-397025-1.00088-9LehericySBensimonGVidailhetM Parkinsonian syndromes. In: TogaAW editor. Brain Mapping (Waltham: Academic Press), 769–85. 10.1016/B978-0-12-397025-1.00088-9, LehericySBensimonGVidailhetM Parkinsonian syndromes. In: TogaAW editor. Brain Mapping (Waltham: Academic Press), 769–85. 10.1016/B978-0-12-397025-1.00088-9
-
(EckertTSailerMKaufmannJSchraderCPeschelTBodammerN. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage. (2004) 21:229–35. 10.1016/j.neuroimage.2003.08.02814741660)
EckertTSailerMKaufmannJSchraderCPeschelTBodammerN. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage. (2004) 21:229–35. 10.1016/j.neuroimage.2003.08.02814741660EckertTSailerMKaufmannJSchraderCPeschelTBodammerN. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage. (2004) 21:229–35. 10.1016/j.neuroimage.2003.08.02814741660, EckertTSailerMKaufmannJSchraderCPeschelTBodammerN. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage. (2004) 21:229–35. 10.1016/j.neuroimage.2003.08.02814741660
-
(MuellerCHusslAKrismerFHeimBMahlknechtPNockerM. The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative Parkinsonism. Parkinsonism Relat Disord. (2018) 54:90–4. 10.1016/j.parkreldis.2018.04.00529643007)
MuellerCHusslAKrismerFHeimBMahlknechtPNockerM. The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative Parkinsonism. Parkinsonism Relat Disord. (2018) 54:90–4. 10.1016/j.parkreldis.2018.04.00529643007MuellerCHusslAKrismerFHeimBMahlknechtPNockerM. The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative Parkinsonism. Parkinsonism Relat Disord. (2018) 54:90–4. 10.1016/j.parkreldis.2018.04.00529643007, MuellerCHusslAKrismerFHeimBMahlknechtPNockerM. The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative Parkinsonism. Parkinsonism Relat Disord. (2018) 54:90–4. 10.1016/j.parkreldis.2018.04.00529643007
-
(ReimãoSPita LoboPNeutelDGuedesLCCoelhoMRosaMM. Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease. Mov Disord. (2015) 30:953–9. 10.1002/mds.2618225758364)
ReimãoSPita LoboPNeutelDGuedesLCCoelhoMRosaMM. Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease. Mov Disord. (2015) 30:953–9. 10.1002/mds.2618225758364ReimãoSPita LoboPNeutelDGuedesLCCoelhoMRosaMM. Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease. Mov Disord. (2015) 30:953–9. 10.1002/mds.2618225758364, ReimãoSPita LoboPNeutelDGuedesLCCoelhoMRosaMM. Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease. Mov Disord. (2015) 30:953–9. 10.1002/mds.2618225758364
-
E. Reiter, Christoph Mueller, Bernadette Pinter, F. Krismer, C. Scherfler, R. Esterhammer, C. Kremser, M. Schocke, G. Wenning, W. Poewe, K. Seppi (2015)
Dorsolateral nigral hyperintensity on 3.0T susceptibility‐weighted imaging in neurodegenerative ParkinsonismMovement Disorders, 30
-
S. Mangesius, A. Hussl, F. Krismer, P. Mahlknecht, E. Reiter, Susanne Tagwercher, A. Djamshidian, M. Schocke, R. Esterhammer, G. Wenning, C. Müller, C. Scherfler, E. Gizewski, W. Poewe, K. Seppi (2018)
MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.Parkinsonism & related disorders, 46
-
(SjöströmHGranbergTWestmanESvenningssonP. Quantitative susceptibility mapping differentiates between Parkinsonian disorders. Parkinsonism Relat Disord. (2017) 44:51–7. 10.1016/j.parkreldis.2017.08.02928886909)
SjöströmHGranbergTWestmanESvenningssonP. Quantitative susceptibility mapping differentiates between Parkinsonian disorders. Parkinsonism Relat Disord. (2017) 44:51–7. 10.1016/j.parkreldis.2017.08.02928886909SjöströmHGranbergTWestmanESvenningssonP. Quantitative susceptibility mapping differentiates between Parkinsonian disorders. Parkinsonism Relat Disord. (2017) 44:51–7. 10.1016/j.parkreldis.2017.08.02928886909, SjöströmHGranbergTWestmanESvenningssonP. Quantitative susceptibility mapping differentiates between Parkinsonian disorders. Parkinsonism Relat Disord. (2017) 44:51–7. 10.1016/j.parkreldis.2017.08.02928886909
-
(KitaoSMatsusueEFujiiSMiyoshiFKaminouTKatoS. Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies. Neuroradiology. (2013) 55:947–53. 10.1007/s00234-013-1199-923673875)
KitaoSMatsusueEFujiiSMiyoshiFKaminouTKatoS. Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies. Neuroradiology. (2013) 55:947–53. 10.1007/s00234-013-1199-923673875KitaoSMatsusueEFujiiSMiyoshiFKaminouTKatoS. Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies. Neuroradiology. (2013) 55:947–53. 10.1007/s00234-013-1199-923673875, KitaoSMatsusueEFujiiSMiyoshiFKaminouTKatoS. Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies. Neuroradiology. (2013) 55:947–53. 10.1007/s00234-013-1199-923673875
-
(DuGLewisMMKanekarSSterlingNWHeLKongL. Combined diffusion tensor imaging and apparent transverse relaxation rate differentiate Parkinson disease and Atypical Parkinsonism. AJNR Am J Neuroradiol. (2017) 38:966–72. 10.3174/ajnr.A513628364007)
DuGLewisMMKanekarSSterlingNWHeLKongL. Combined diffusion tensor imaging and apparent transverse relaxation rate differentiate Parkinson disease and Atypical Parkinsonism. AJNR Am J Neuroradiol. (2017) 38:966–72. 10.3174/ajnr.A513628364007DuGLewisMMKanekarSSterlingNWHeLKongL. Combined diffusion tensor imaging and apparent transverse relaxation rate differentiate Parkinson disease and Atypical Parkinsonism. AJNR Am J Neuroradiol. (2017) 38:966–72. 10.3174/ajnr.A513628364007, DuGLewisMMKanekarSSterlingNWHeLKongL. Combined diffusion tensor imaging and apparent transverse relaxation rate differentiate Parkinson disease and Atypical Parkinsonism. AJNR Am J Neuroradiol. (2017) 38:966–72. 10.3174/ajnr.A513628364007
-
(YoonRGKimSJKimHSChoiCGKimJSOhJ. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography. Neurosci Lett. (2015) 584:296–301. 10.1016/j.neulet.2014.10.04625450142)
YoonRGKimSJKimHSChoiCGKimJSOhJ. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography. Neurosci Lett. (2015) 584:296–301. 10.1016/j.neulet.2014.10.04625450142YoonRGKimSJKimHSChoiCGKimJSOhJ. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography. Neurosci Lett. (2015) 584:296–301. 10.1016/j.neulet.2014.10.04625450142, YoonRGKimSJKimHSChoiCGKimJSOhJ. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography. Neurosci Lett. (2015) 584:296–301. 10.1016/j.neulet.2014.10.04625450142
-
(PyatigorskayaNMonginMValabregueRYahia-CherifLEwenczykCPouponC. Medulla oblongata damage and cardiac autonomic dysfunction in Parkinson disease. Neurology. (2016) 87:2540–5. 10.1212/WNL.000000000000342627837003)
PyatigorskayaNMonginMValabregueRYahia-CherifLEwenczykCPouponC. Medulla oblongata damage and cardiac autonomic dysfunction in Parkinson disease. Neurology. (2016) 87:2540–5. 10.1212/WNL.000000000000342627837003PyatigorskayaNMonginMValabregueRYahia-CherifLEwenczykCPouponC. Medulla oblongata damage and cardiac autonomic dysfunction in Parkinson disease. Neurology. (2016) 87:2540–5. 10.1212/WNL.000000000000342627837003, PyatigorskayaNMonginMValabregueRYahia-CherifLEwenczykCPouponC. Medulla oblongata damage and cardiac autonomic dysfunction in Parkinson disease. Neurology. (2016) 87:2540–5. 10.1212/WNL.000000000000342627837003
-
R. Yoon, Sang Kim, H. Kim, C. Choi, Jae Kim, Jungsu Oh, S. Chung, C. Lee (2015)
The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson’s disease: Correlation with 18F-flurodeoxyglucose positron-emission tomographyNeuroscience Letters, 584
-
Y. Compta, J. Pereira, José Ríos, N. Ibarretxe‐Bilbao, C. Junqué, N. Bargalló, A. Cámara, M. Buongiorno, M. Fernández, Claustre Pont‐Sunyer, M. Marti (2013)
Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study.Parkinsonism & related disorders, 19 8
-
P. Damier, E. Hirsch, Y. Agid, A. Graybiel (1999)
The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.Brain : a journal of neurology, 122 ( Pt 8)
-
(WhitwellJLJackCRBoeveBFParisiJEAhlskogJEDrubachDA. Imaging correlates of pathology in corticobasal syndrome. Neurology. (2010) 75:1879–87. 10.1212/WNL.0b013e3181feb2e821098403)
WhitwellJLJackCRBoeveBFParisiJEAhlskogJEDrubachDA. Imaging correlates of pathology in corticobasal syndrome. Neurology. (2010) 75:1879–87. 10.1212/WNL.0b013e3181feb2e821098403WhitwellJLJackCRBoeveBFParisiJEAhlskogJEDrubachDA. Imaging correlates of pathology in corticobasal syndrome. Neurology. (2010) 75:1879–87. 10.1212/WNL.0b013e3181feb2e821098403, WhitwellJLJackCRBoeveBFParisiJEAhlskogJEDrubachDA. Imaging correlates of pathology in corticobasal syndrome. Neurology. (2010) 75:1879–87. 10.1212/WNL.0b013e3181feb2e821098403
-
Raquel Gardner, A. Boxer, Andrew Trujillo, J. Mirsky, C. Guo, Efstathios Gennatas, H. Heuer, E. Fine, Juan Zhou, J. Kramer, B. Miller, W. Seeley (2013)
Intrinsic connectivity network disruption in progressive supranuclear palsyAnnals of Neurology, 73
-
K. Josephs, J. Duffy, E. Strand, M. Machulda, M. Senjem, Ankit Master, V. Lowe, C. Jack, J. Whitwell (2012)
Characterizing a neurodegenerative syndrome: primary progressive apraxia of speechBrain, 135
-
(KataokaHNishimoriYKiriyamaTNanauraHIzumiTEuraN. Increased signal in the superior cerebellar peduncle of patients with progressive Supranuclear Palsy. J Mov Disord. (2019) 12:166–71. 10.14802/jmd.19002 31390857)
KataokaHNishimoriYKiriyamaTNanauraHIzumiTEuraN. Increased signal in the superior cerebellar peduncle of patients with progressive Supranuclear Palsy. J Mov Disord. (2019) 12:166–71. 10.14802/jmd.19002 31390857KataokaHNishimoriYKiriyamaTNanauraHIzumiTEuraN. Increased signal in the superior cerebellar peduncle of patients with progressive Supranuclear Palsy. J Mov Disord. (2019) 12:166–71. 10.14802/jmd.19002 31390857, KataokaHNishimoriYKiriyamaTNanauraHIzumiTEuraN. Increased signal in the superior cerebellar peduncle of patients with progressive Supranuclear Palsy. J Mov Disord. (2019) 12:166–71. 10.14802/jmd.19002 31390857
-
(DicksonDW. Parkinson's disease and Parkinsonism: neuropathology. Cold Spring Harb Perspect Med. (2012) 2:a009258. 10.1101/cshperspect.a00925822908195)
DicksonDW. Parkinson's disease and Parkinsonism: neuropathology. Cold Spring Harb Perspect Med. (2012) 2:a009258. 10.1101/cshperspect.a00925822908195DicksonDW. Parkinson's disease and Parkinsonism: neuropathology. Cold Spring Harb Perspect Med. (2012) 2:a009258. 10.1101/cshperspect.a00925822908195, DicksonDW. Parkinson's disease and Parkinsonism: neuropathology. Cold Spring Harb Perspect Med. (2012) 2:a009258. 10.1101/cshperspect.a00925822908195
-
(OforiEPasternakOPlanettaPJLiHBurciuRGSnyderAF. Longitudinal changes in free-water within the substantia nigra of Parkinson's disease. Brain. (2015) 138:2322–31. 10.1093/brain/awv13625981960)
OforiEPasternakOPlanettaPJLiHBurciuRGSnyderAF. Longitudinal changes in free-water within the substantia nigra of Parkinson's disease. Brain. (2015) 138:2322–31. 10.1093/brain/awv13625981960OforiEPasternakOPlanettaPJLiHBurciuRGSnyderAF. Longitudinal changes in free-water within the substantia nigra of Parkinson's disease. Brain. (2015) 138:2322–31. 10.1093/brain/awv13625981960, OforiEPasternakOPlanettaPJLiHBurciuRGSnyderAF. Longitudinal changes in free-water within the substantia nigra of Parkinson's disease. Brain. (2015) 138:2322–31. 10.1093/brain/awv13625981960
-
(LehéricySHartmannALannuzelAGalanaudDDelmaireCBienaiméeM-J. Magnetic resonance imaging lesion pattern in Guadeloupean Parkinsonism is distinct from progressive supranuclear palsy. Brain. (2010) 133:2410–25. 10.1093/brain/awq16220826434)
LehéricySHartmannALannuzelAGalanaudDDelmaireCBienaiméeM-J. Magnetic resonance imaging lesion pattern in Guadeloupean Parkinsonism is distinct from progressive supranuclear palsy. Brain. (2010) 133:2410–25. 10.1093/brain/awq16220826434LehéricySHartmannALannuzelAGalanaudDDelmaireCBienaiméeM-J. Magnetic resonance imaging lesion pattern in Guadeloupean Parkinsonism is distinct from progressive supranuclear palsy. Brain. (2010) 133:2410–25. 10.1093/brain/awq16220826434, LehéricySHartmannALannuzelAGalanaudDDelmaireCBienaiméeM-J. Magnetic resonance imaging lesion pattern in Guadeloupean Parkinsonism is distinct from progressive supranuclear palsy. Brain. (2010) 133:2410–25. 10.1093/brain/awq16220826434
-
(ArcherDBBrickerJTChuWTBurciuRGMcCrackenJL. Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multicentre Machine Learning Study–The Lancet Digital Health. Available online at: https://www.thelancet.com/journals/landig/article/PIIS2589-7500(19)30105-0/fulltext (accessed December 13, 2019).)
ArcherDBBrickerJTChuWTBurciuRGMcCrackenJL. Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multicentre Machine Learning Study–The Lancet Digital Health. Available online at: https://www.thelancet.com/journals/landig/article/PIIS2589-7500(19)30105-0/fulltext (accessed December 13, 2019).ArcherDBBrickerJTChuWTBurciuRGMcCrackenJL. Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multicentre Machine Learning Study–The Lancet Digital Health. Available online at: https://www.thelancet.com/journals/landig/article/PIIS2589-7500(19)30105-0/fulltext (accessed December 13, 2019)., ArcherDBBrickerJTChuWTBurciuRGMcCrackenJL. Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multicentre Machine Learning Study–The Lancet Digital Health. Available online at: https://www.thelancet.com/journals/landig/article/PIIS2589-7500(19)30105-0/fulltext (accessed December 13, 2019).
-
C. Cassidy, F. Zucca, R. Girgis, Seth Baker, J. Weinstein, M. Sharp, C. Bellei, A. Valmadre, Nora Vanegas, L. Kegeles, G. Brucato, U. Kang, D. Sulzer, L. Zecca, A. Abi-Dargham, Guillermo Horga (2019)
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brainProceedings of the National Academy of Sciences, 116
-
(LehéricySBardinetEPouponCVidailhetMFrançoisC. 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease. Mov Disord. (2014) 29:1574–81. 10.1002/mds.2604325308960)
LehéricySBardinetEPouponCVidailhetMFrançoisC. 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease. Mov Disord. (2014) 29:1574–81. 10.1002/mds.2604325308960LehéricySBardinetEPouponCVidailhetMFrançoisC. 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease. Mov Disord. (2014) 29:1574–81. 10.1002/mds.2604325308960, LehéricySBardinetEPouponCVidailhetMFrançoisC. 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease. Mov Disord. (2014) 29:1574–81. 10.1002/mds.2604325308960
-
(PostumaRBBergDSternMPoeweWOlanowCWOertelW MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. (2015) 30:1591–601. 10.1002/mds.2642426474316)
PostumaRBBergDSternMPoeweWOlanowCWOertelW MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. (2015) 30:1591–601. 10.1002/mds.2642426474316PostumaRBBergDSternMPoeweWOlanowCWOertelW MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. (2015) 30:1591–601. 10.1002/mds.2642426474316, PostumaRBBergDSternMPoeweWOlanowCWOertelW MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. (2015) 30:1591–601. 10.1002/mds.2642426474316
-
(MöllerLKassubekJSüdmeyerMHilkerRHattingenEEggerK. Manual MRI morphometry in Parkinsonian syndromes. Mov Disord. (2017) 32:778–82. 10.1002/mds.2692128150443)
MöllerLKassubekJSüdmeyerMHilkerRHattingenEEggerK. Manual MRI morphometry in Parkinsonian syndromes. Mov Disord. (2017) 32:778–82. 10.1002/mds.2692128150443MöllerLKassubekJSüdmeyerMHilkerRHattingenEEggerK. Manual MRI morphometry in Parkinsonian syndromes. Mov Disord. (2017) 32:778–82. 10.1002/mds.2692128150443, MöllerLKassubekJSüdmeyerMHilkerRHattingenEEggerK. Manual MRI morphometry in Parkinsonian syndromes. Mov Disord. (2017) 32:778–82. 10.1002/mds.2692128150443
-
(DeistungASchäferASchweserFBiedermannUTurnerRReichenbachJR. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. Neuroimage. (2013) 65:299–314. 10.1016/j.neuroimage.2012.09.05523036448)
DeistungASchäferASchweserFBiedermannUTurnerRReichenbachJR. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. Neuroimage. (2013) 65:299–314. 10.1016/j.neuroimage.2012.09.05523036448DeistungASchäferASchweserFBiedermannUTurnerRReichenbachJR. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. Neuroimage. (2013) 65:299–314. 10.1016/j.neuroimage.2012.09.05523036448, DeistungASchäferASchweserFBiedermannUTurnerRReichenbachJR. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. Neuroimage. (2013) 65:299–314. 10.1016/j.neuroimage.2012.09.05523036448
-
F. Federico, D. Mezzapesa, M. Petruzzellis (2008)
Parkinsonian syndromesNeurological Sciences, 29
-
D. Dickson (2012)
Parkinson's disease and parkinsonism: neuropathology.Cold Spring Harbor perspectives in medicine, 2 8
-
C. Salvatore, A. Cerasa, I. Castiglioni, F. Gallivanone, A. Augimeri, M. Lopez, G. Arabia, M. Morelli, M. Gilardi, A. Quattrone (2014)
Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear PalsyJournal of Neuroscience Methods, 222
-
Y. Surova, M. Nilsson, J. Lätt, Björn Lampinen, O. Lindberg, S. Hall, H. Widner, C. Nilsson, D. Westen, O. Hansson (2015)
Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsyNeuroradiology, 57
-
F. Agosta, E. Sarasso, M. Filippi (2018)
Functional MRI in Atypical Parkinsonisms.International review of neurobiology, 142
-
D. Messina, A. Cerasa, F. Condino, G. Arabia, F. Novellino, G. Nicoletti, M. Salsone, M. Morelli, P. Lanza, A. Quattrone (2011)
Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.Parkinsonism & related disorders, 17 3
-
(BarbosaJHOSantosACTumasVLiuMZhengWHaackeEM. Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2. Magn Reson Imaging. (2015) 33:559–65. 10.1016/j.mri.2015.02.02125721997)
BarbosaJHOSantosACTumasVLiuMZhengWHaackeEM. Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2. Magn Reson Imaging. (2015) 33:559–65. 10.1016/j.mri.2015.02.02125721997BarbosaJHOSantosACTumasVLiuMZhengWHaackeEM. Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2. Magn Reson Imaging. (2015) 33:559–65. 10.1016/j.mri.2015.02.02125721997, BarbosaJHOSantosACTumasVLiuMZhengWHaackeEM. Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2. Magn Reson Imaging. (2015) 33:559–65. 10.1016/j.mri.2015.02.02125721997
-
(GardnerRCBoxerALTrujilloAMirskyJBGuoCCGennatasED. Intrinsic connectivity network disruption in progressive supranuclear palsy. Ann Neurol. (2013) 73:603–16. 10.1002/ana.2384423536287)
GardnerRCBoxerALTrujilloAMirskyJBGuoCCGennatasED. Intrinsic connectivity network disruption in progressive supranuclear palsy. Ann Neurol. (2013) 73:603–16. 10.1002/ana.2384423536287GardnerRCBoxerALTrujilloAMirskyJBGuoCCGennatasED. Intrinsic connectivity network disruption in progressive supranuclear palsy. Ann Neurol. (2013) 73:603–16. 10.1002/ana.2384423536287, GardnerRCBoxerALTrujilloAMirskyJBGuoCCGennatasED. Intrinsic connectivity network disruption in progressive supranuclear palsy. Ann Neurol. (2013) 73:603–16. 10.1002/ana.2384423536287
-
(ComptaYPereiraJBRíosJIbarretxe-BilbaoNJunquéCBargallóN. Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study. Parkinsonism Relat Disord. (2013) 19:717–24. 10.1016/j.parkreldis.2013.03.00923643469)
ComptaYPereiraJBRíosJIbarretxe-BilbaoNJunquéCBargallóN. Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study. Parkinsonism Relat Disord. (2013) 19:717–24. 10.1016/j.parkreldis.2013.03.00923643469ComptaYPereiraJBRíosJIbarretxe-BilbaoNJunquéCBargallóN. Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study. Parkinsonism Relat Disord. (2013) 19:717–24. 10.1016/j.parkreldis.2013.03.00923643469, ComptaYPereiraJBRíosJIbarretxe-BilbaoNJunquéCBargallóN. Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study. Parkinsonism Relat Disord. (2013) 19:717–24. 10.1016/j.parkreldis.2013.03.00923643469
-
A. Galbiati, Laura Verga, E. Giora, M. Zucconi, L. Ferini-Strambi (2019)
The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies.Sleep medicine reviews, 43
-
(LeeJ-HHanY-HKangB-MMunC-WLeeS-JBaikS-K. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and Parkinsonian variant of multiple system atrophy. J Neurol. (2013) 260:2094–101. 10.1007/s00415-013-6951-x23670309)
LeeJ-HHanY-HKangB-MMunC-WLeeS-JBaikS-K. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and Parkinsonian variant of multiple system atrophy. J Neurol. (2013) 260:2094–101. 10.1007/s00415-013-6951-x23670309LeeJ-HHanY-HKangB-MMunC-WLeeS-JBaikS-K. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and Parkinsonian variant of multiple system atrophy. J Neurol. (2013) 260:2094–101. 10.1007/s00415-013-6951-x23670309, LeeJ-HHanY-HKangB-MMunC-WLeeS-JBaikS-K. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and Parkinsonian variant of multiple system atrophy. J Neurol. (2013) 260:2094–101. 10.1007/s00415-013-6951-x23670309
-
(ObaHYagishitaATeradaHBarkovichAJKutomiKYamauchiT. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology. (2005) 64:2050–5. 10.1212/01.WNL.0000165960.04422.D015985570)
ObaHYagishitaATeradaHBarkovichAJKutomiKYamauchiT. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology. (2005) 64:2050–5. 10.1212/01.WNL.0000165960.04422.D015985570ObaHYagishitaATeradaHBarkovichAJKutomiKYamauchiT. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology. (2005) 64:2050–5. 10.1212/01.WNL.0000165960.04422.D015985570, ObaHYagishitaATeradaHBarkovichAJKutomiKYamauchiT. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology. (2005) 64:2050–5. 10.1212/01.WNL.0000165960.04422.D015985570
-
(MahlknechtPKrismerFPoeweWSeppiK. Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease. Mov Disord. (2017) 32:619–23. 10.1002/mds.2693228151553)
MahlknechtPKrismerFPoeweWSeppiK. Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease. Mov Disord. (2017) 32:619–23. 10.1002/mds.2693228151553MahlknechtPKrismerFPoeweWSeppiK. Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease. Mov Disord. (2017) 32:619–23. 10.1002/mds.2693228151553, MahlknechtPKrismerFPoeweWSeppiK. Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease. Mov Disord. (2017) 32:619–23. 10.1002/mds.2693228151553
-
Way (2019)
The “hot cross bun” sign is not always multiple system Atrophy: etiologies of 11 casesJ Mov Disord., 12
-
S. Zanigni, S. Evangelisti, C. Testa, D. Manners, G. Calandra-Buonaura, M. Guarino, A. Gabellini, L. Gramegna, G. Giannini, L. Sambati, P. Cortelli, R. Lodi, C. Tonon (2017)
White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study.Parkinsonism & related disorders, 39
-
(SchockeMFHSeppiKEsterhammerRKremserCMairKJCzermakBV. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage. (2004) 21:1443–51. 10.1016/j.neuroimage.2003.12.00515050569)
SchockeMFHSeppiKEsterhammerRKremserCMairKJCzermakBV. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage. (2004) 21:1443–51. 10.1016/j.neuroimage.2003.12.00515050569SchockeMFHSeppiKEsterhammerRKremserCMairKJCzermakBV. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage. (2004) 21:1443–51. 10.1016/j.neuroimage.2003.12.00515050569, SchockeMFHSeppiKEsterhammerRKremserCMairKJCzermakBV. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage. (2004) 21:1443–51. 10.1016/j.neuroimage.2003.12.00515050569
-
(WatanabeHSaitoYTeraoSAndoTKachiTMukaiE. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain. (2002) 125:1070–83. 10.1093/brain/awf11711960896)
WatanabeHSaitoYTeraoSAndoTKachiTMukaiE. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain. (2002) 125:1070–83. 10.1093/brain/awf11711960896WatanabeHSaitoYTeraoSAndoTKachiTMukaiE. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain. (2002) 125:1070–83. 10.1093/brain/awf11711960896, WatanabeHSaitoYTeraoSAndoTKachiTMukaiE. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain. (2002) 125:1070–83. 10.1093/brain/awf11711960896
-
N. Kato, K. Arai, T. Hattori (2003)
Study of the rostral midbrain atrophy in progressive supranuclear palsyJournal of the Neurological Sciences, 210
-
(DavieCABarkerGJMachadoCMillerDHLeesAJ. Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome. Mov Disord. (1997) 12:767–71. 10.1002/mds.8701205259380064)
DavieCABarkerGJMachadoCMillerDHLeesAJ. Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome. Mov Disord. (1997) 12:767–71. 10.1002/mds.8701205259380064DavieCABarkerGJMachadoCMillerDHLeesAJ. Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome. Mov Disord. (1997) 12:767–71. 10.1002/mds.8701205259380064, DavieCABarkerGJMachadoCMillerDHLeesAJ. Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome. Mov Disord. (1997) 12:767–71. 10.1002/mds.8701205259380064
-
(AgostaFKostićVSGalantucciSMesarosSSvetelMPaganiE. The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-Parkinsonism: a VBM-DARTEL study. Eur J Neurosci. (2010) 32:640–7. 10.1111/j.1460-9568.2010.07304.x20597976)
AgostaFKostićVSGalantucciSMesarosSSvetelMPaganiE. The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-Parkinsonism: a VBM-DARTEL study. Eur J Neurosci. (2010) 32:640–7. 10.1111/j.1460-9568.2010.07304.x20597976AgostaFKostićVSGalantucciSMesarosSSvetelMPaganiE. The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-Parkinsonism: a VBM-DARTEL study. Eur J Neurosci. (2010) 32:640–7. 10.1111/j.1460-9568.2010.07304.x20597976, AgostaFKostićVSGalantucciSMesarosSSvetelMPaganiE. The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-Parkinsonism: a VBM-DARTEL study. Eur J Neurosci. (2010) 32:640–7. 10.1111/j.1460-9568.2010.07304.x20597976
-
C. Cochrane, Klaus Ebmeier (2013)
Diffusion tensor imaging in parkinsonian syndromesNeurology, 80
-
(RighiniAAntoniniADe NotarisRBianchiniEMeucciNSacilottoG. MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol. (2004) 25:927–32.15205125)
RighiniAAntoniniADe NotarisRBianchiniEMeucciNSacilottoG. MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol. (2004) 25:927–32.15205125RighiniAAntoniniADe NotarisRBianchiniEMeucciNSacilottoG. MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol. (2004) 25:927–32.15205125, RighiniAAntoniniADe NotarisRBianchiniEMeucciNSacilottoG. MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol. (2004) 25:927–32.15205125
-
R. Castellani (1998)
Multiple System Atrophy : Clues from InclusionsAmerican Journal of Pathology, 153
-
(QuattroneANicolettiGMessinaDFeraFCondinoFPuglieseP. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology. (2008) 246:214–21. 10.1148/radiol.245306170317991785)
QuattroneANicolettiGMessinaDFeraFCondinoFPuglieseP. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology. (2008) 246:214–21. 10.1148/radiol.245306170317991785QuattroneANicolettiGMessinaDFeraFCondinoFPuglieseP. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology. (2008) 246:214–21. 10.1148/radiol.245306170317991785, QuattroneANicolettiGMessinaDFeraFCondinoFPuglieseP. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology. (2008) 246:214–21. 10.1148/radiol.245306170317991785
-
J. Levin, A. Kurz, T. Arzberger, A. Giese, G. Höglinger (2016)
The Differential Diagnosis and Treatment of Atypical Parkinsonism.Deutsches Arzteblatt international, 113 5
-
H. Sjöström, T. Granberg, E. Westman, P. Svenningsson (2017)
Quantitative susceptibility mapping differentiates between parkinsonian disorders.Parkinsonism & related disorders, 44
-
(MahlknechtPHotterAHusslAEsterhammerRSchockeMSeppiK. Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease. Neurodegener Dis. (2010) 7:300–18. 10.1159/00031449520616565)
MahlknechtPHotterAHusslAEsterhammerRSchockeMSeppiK. Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease. Neurodegener Dis. (2010) 7:300–18. 10.1159/00031449520616565MahlknechtPHotterAHusslAEsterhammerRSchockeMSeppiK. Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease. Neurodegener Dis. (2010) 7:300–18. 10.1159/00031449520616565, MahlknechtPHotterAHusslAEsterhammerRSchockeMSeppiK. Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease. Neurodegener Dis. (2010) 7:300–18. 10.1159/00031449520616565
-
(WatanabeHItoMFukatsuHSendaJAtsutaNKagaT. Putaminal magnetic resonance imaging features at various magnetic field strengths in multiple system atrophy. Mov Disord. (2010) 25:1916–23. 10.1002/mds.2319620623769)
WatanabeHItoMFukatsuHSendaJAtsutaNKagaT. Putaminal magnetic resonance imaging features at various magnetic field strengths in multiple system atrophy. Mov Disord. (2010) 25:1916–23. 10.1002/mds.2319620623769WatanabeHItoMFukatsuHSendaJAtsutaNKagaT. Putaminal magnetic resonance imaging features at various magnetic field strengths in multiple system atrophy. Mov Disord. (2010) 25:1916–23. 10.1002/mds.2319620623769, WatanabeHItoMFukatsuHSendaJAtsutaNKagaT. Putaminal magnetic resonance imaging features at various magnetic field strengths in multiple system atrophy. Mov Disord. (2010) 25:1916–23. 10.1002/mds.2319620623769
-
(WhitwellJLHöglingerGUAntoniniABordelonYBoxerALColosimoC. Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be? Mov Disord. (2017) 32:955–71. 10.1002/mds.2703828500751)
WhitwellJLHöglingerGUAntoniniABordelonYBoxerALColosimoC. Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be? Mov Disord. (2017) 32:955–71. 10.1002/mds.2703828500751WhitwellJLHöglingerGUAntoniniABordelonYBoxerALColosimoC. Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be? Mov Disord. (2017) 32:955–71. 10.1002/mds.2703828500751, WhitwellJLHöglingerGUAntoniniABordelonYBoxerALColosimoC. Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be? Mov Disord. (2017) 32:955–71. 10.1002/mds.2703828500751
-
(KaliaLVLangAE. Parkinson's disease. Lancet. (2015) 386:896–912. 10.1016/S0140-6736(14)61393-325904081)
KaliaLVLangAE. Parkinson's disease. Lancet. (2015) 386:896–912. 10.1016/S0140-6736(14)61393-325904081KaliaLVLangAE. Parkinson's disease. Lancet. (2015) 386:896–912. 10.1016/S0140-6736(14)61393-325904081, KaliaLVLangAE. Parkinson's disease. Lancet. (2015) 386:896–912. 10.1016/S0140-6736(14)61393-325904081
-
(LehericySVaillancourtDESeppiKMonchiORektorovaIAntoniniA. The role of high-field magnetic resonance imaging in Parkinsonian disorders: pushing the boundaries forward. Mov Disord. (2017) 32:510–25. 10.1002/mds.2696828370449)
LehericySVaillancourtDESeppiKMonchiORektorovaIAntoniniA. The role of high-field magnetic resonance imaging in Parkinsonian disorders: pushing the boundaries forward. Mov Disord. (2017) 32:510–25. 10.1002/mds.2696828370449LehericySVaillancourtDESeppiKMonchiORektorovaIAntoniniA. The role of high-field magnetic resonance imaging in Parkinsonian disorders: pushing the boundaries forward. Mov Disord. (2017) 32:510–25. 10.1002/mds.2696828370449, LehericySVaillancourtDESeppiKMonchiORektorovaIAntoniniA. The role of high-field magnetic resonance imaging in Parkinsonian disorders: pushing the boundaries forward. Mov Disord. (2017) 32:510–25. 10.1002/mds.2696828370449
-
(SaeedUCompagnoneJAvivRIStrafellaAPBlackSELangAE. Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts. Transl Neurodegener. (2017) 6:8. 10.1186/s40035-017-0076-628360997)
SaeedUCompagnoneJAvivRIStrafellaAPBlackSELangAE. Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts. Transl Neurodegener. (2017) 6:8. 10.1186/s40035-017-0076-628360997SaeedUCompagnoneJAvivRIStrafellaAPBlackSELangAE. Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts. Transl Neurodegener. (2017) 6:8. 10.1186/s40035-017-0076-628360997, SaeedUCompagnoneJAvivRIStrafellaAPBlackSELangAE. Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts. Transl Neurodegener. (2017) 6:8. 10.1186/s40035-017-0076-628360997
-
(NigroSAntoniniAVaillancourtDESeppiKCeravoloRStrafellaAP. Automated MRI classification in progressive Supranuclear palsy: a large International Cohort study. Mov Disord. (2020) 35:976–83. 10.1002/mds.2800732092195)
NigroSAntoniniAVaillancourtDESeppiKCeravoloRStrafellaAP. Automated MRI classification in progressive Supranuclear palsy: a large International Cohort study. Mov Disord. (2020) 35:976–83. 10.1002/mds.2800732092195NigroSAntoniniAVaillancourtDESeppiKCeravoloRStrafellaAP. Automated MRI classification in progressive Supranuclear palsy: a large International Cohort study. Mov Disord. (2020) 35:976–83. 10.1002/mds.2800732092195, NigroSAntoniniAVaillancourtDESeppiKCeravoloRStrafellaAP. Automated MRI classification in progressive Supranuclear palsy: a large International Cohort study. Mov Disord. (2020) 35:976–83. 10.1002/mds.2800732092195
-
S. Lehéricy, D. Vaillancourt, K. Seppi, O. Monchi, I. Rektorová, A. Antonini, M. McKeown, M. Masellis, D. Berg, J. Rowe, S. Lewis, C. Williams-Gray, A. Tessitore, H. Siebner (2017)
The role of high‐field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forwardMovement Disorders, 32
-
(PaviourDCPriceSLJahanshahiMLeesAJFoxNC. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain. (2006) 129:1040–9. 10.1093/brain/awl02116455792)
PaviourDCPriceSLJahanshahiMLeesAJFoxNC. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain. (2006) 129:1040–9. 10.1093/brain/awl02116455792PaviourDCPriceSLJahanshahiMLeesAJFoxNC. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain. (2006) 129:1040–9. 10.1093/brain/awl02116455792, PaviourDCPriceSLJahanshahiMLeesAJFoxNC. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain. (2006) 129:1040–9. 10.1093/brain/awl02116455792
-
(PostumaRBGagnonJFVendetteMFantiniMLMassicotte-MarquezJMontplaisirJ. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. (2009) 72:1296–300. 10.1212/01.wnl.0000340980.19702.6e19109537)
PostumaRBGagnonJFVendetteMFantiniMLMassicotte-MarquezJMontplaisirJ. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. (2009) 72:1296–300. 10.1212/01.wnl.0000340980.19702.6e19109537PostumaRBGagnonJFVendetteMFantiniMLMassicotte-MarquezJMontplaisirJ. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. (2009) 72:1296–300. 10.1212/01.wnl.0000340980.19702.6e19109537, PostumaRBGagnonJFVendetteMFantiniMLMassicotte-MarquezJMontplaisirJ. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. (2009) 72:1296–300. 10.1212/01.wnl.0000340980.19702.6e19109537
-
(QuattroneAMorelliMNigroSQuattroneAVescioBArabiaG. A new MR imaging index for differentiation of progressive supranuclear palsy-Parkinsonism from Parkinson's disease. Parkinsonism Relat Disord. (2018) 54:3–8. 10.1016/j.parkreldis.2018.07.01630068492)
QuattroneAMorelliMNigroSQuattroneAVescioBArabiaG. A new MR imaging index for differentiation of progressive supranuclear palsy-Parkinsonism from Parkinson's disease. Parkinsonism Relat Disord. (2018) 54:3–8. 10.1016/j.parkreldis.2018.07.01630068492QuattroneAMorelliMNigroSQuattroneAVescioBArabiaG. A new MR imaging index for differentiation of progressive supranuclear palsy-Parkinsonism from Parkinson's disease. Parkinsonism Relat Disord. (2018) 54:3–8. 10.1016/j.parkreldis.2018.07.01630068492, QuattroneAMorelliMNigroSQuattroneAVescioBArabiaG. A new MR imaging index for differentiation of progressive supranuclear palsy-Parkinsonism from Parkinson's disease. Parkinsonism Relat Disord. (2018) 54:3–8. 10.1016/j.parkreldis.2018.07.01630068492
-
A. Righini, A. Antonini, R. Notaris, E. Bianchini, N. Meucci, G. Sacilotto, M. Canesi, D. Gaspari, F. Triulzi, G. Pezzoli (2004)
MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease.AJNR. American journal of neuroradiology, 25 6
-
(PéranPBarbagalloGNemmiFSierraMGalitzkyMTraonAP-L. MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy. Mov Disord. (2018) 33:600–8. 10.1002/mds.2730729473662)
PéranPBarbagalloGNemmiFSierraMGalitzkyMTraonAP-L. MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy. Mov Disord. (2018) 33:600–8. 10.1002/mds.2730729473662PéranPBarbagalloGNemmiFSierraMGalitzkyMTraonAP-L. MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy. Mov Disord. (2018) 33:600–8. 10.1002/mds.2730729473662, PéranPBarbagalloGNemmiFSierraMGalitzkyMTraonAP-L. MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy. Mov Disord. (2018) 33:600–8. 10.1002/mds.2730729473662
-
(FearnleyJMLeesAJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. (1991) 114 (Pt 5):2283–301. 10.1093/brain/114.5.22831933245)
FearnleyJMLeesAJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. (1991) 114 (Pt 5):2283–301. 10.1093/brain/114.5.22831933245FearnleyJMLeesAJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. (1991) 114 (Pt 5):2283–301. 10.1093/brain/114.5.22831933245, FearnleyJMLeesAJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. (1991) 114 (Pt 5):2283–301. 10.1093/brain/114.5.22831933245
-
(SulzerDCassidyCHorgaGKangUJFahnSCasellaL. Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease. NPJ Parkinson's Dis. (2018) 4:11. 10.1038/s41531-018-0047-329644335)
SulzerDCassidyCHorgaGKangUJFahnSCasellaL. Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease. NPJ Parkinson's Dis. (2018) 4:11. 10.1038/s41531-018-0047-329644335SulzerDCassidyCHorgaGKangUJFahnSCasellaL. Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease. NPJ Parkinson's Dis. (2018) 4:11. 10.1038/s41531-018-0047-329644335, SulzerDCassidyCHorgaGKangUJFahnSCasellaL. Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease. NPJ Parkinson's Dis. (2018) 4:11. 10.1038/s41531-018-0047-329644335
-
(VaillancourtDESprakerMBProdoehlJAbrahamICorcosDMZhouXJ. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology. (2009) 72:1378–84. 10.1212/01.wnl.0000340982.01727.6e19129507)
VaillancourtDESprakerMBProdoehlJAbrahamICorcosDMZhouXJ. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology. (2009) 72:1378–84. 10.1212/01.wnl.0000340982.01727.6e19129507VaillancourtDESprakerMBProdoehlJAbrahamICorcosDMZhouXJ. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology. (2009) 72:1378–84. 10.1212/01.wnl.0000340982.01727.6e19129507, VaillancourtDESprakerMBProdoehlJAbrahamICorcosDMZhouXJ. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology. (2009) 72:1378–84. 10.1212/01.wnl.0000340982.01727.6e19129507
-
(SchwarzSTAbaeiMGontuVMorganPSBajajNAuerDP. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: a region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin. (2013) 3:481–8. 10.1016/j.nicl.2013.10.00624273730)
SchwarzSTAbaeiMGontuVMorganPSBajajNAuerDP. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: a region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin. (2013) 3:481–8. 10.1016/j.nicl.2013.10.00624273730SchwarzSTAbaeiMGontuVMorganPSBajajNAuerDP. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: a region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin. (2013) 3:481–8. 10.1016/j.nicl.2013.10.00624273730, SchwarzSTAbaeiMGontuVMorganPSBajajNAuerDP. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: a region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin. (2013) 3:481–8. 10.1016/j.nicl.2013.10.00624273730
-
(WayCPetterssonDHillerA. The “hot cross bun” sign is not always multiple system Atrophy: etiologies of 11 cases. J Mov Disord. (2019) 12:27–30. 10.14802/jmd.1830563313)
WayCPetterssonDHillerA. The “hot cross bun” sign is not always multiple system Atrophy: etiologies of 11 cases. J Mov Disord. (2019) 12:27–30. 10.14802/jmd.1830563313WayCPetterssonDHillerA. The “hot cross bun” sign is not always multiple system Atrophy: etiologies of 11 cases. J Mov Disord. (2019) 12:27–30. 10.14802/jmd.1830563313, WayCPetterssonDHillerA. The “hot cross bun” sign is not always multiple system Atrophy: etiologies of 11 cases. J Mov Disord. (2019) 12:27–30. 10.14802/jmd.1830563313
-
(GalbiatiAVergaLGioraEZucconiMFerini-StrambiL. The risk of neurodegeneration in REM sleep behavior disorder: a systematic review and meta-analysis of longitudinal studies. Sleep Med Rev. (2019) 43:37–46. 10.1016/j.smrv.2018.09.00830503716)
GalbiatiAVergaLGioraEZucconiMFerini-StrambiL. The risk of neurodegeneration in REM sleep behavior disorder: a systematic review and meta-analysis of longitudinal studies. Sleep Med Rev. (2019) 43:37–46. 10.1016/j.smrv.2018.09.00830503716GalbiatiAVergaLGioraEZucconiMFerini-StrambiL. The risk of neurodegeneration in REM sleep behavior disorder: a systematic review and meta-analysis of longitudinal studies. Sleep Med Rev. (2019) 43:37–46. 10.1016/j.smrv.2018.09.00830503716, GalbiatiAVergaLGioraEZucconiMFerini-StrambiL. The risk of neurodegeneration in REM sleep behavior disorder: a systematic review and meta-analysis of longitudinal studies. Sleep Med Rev. (2019) 43:37–46. 10.1016/j.smrv.2018.09.00830503716
-
(Delgado-AlvaradoMGagoBNavalpotro-GomezIJiménez-UrbietaHRodriguez-OrozMC. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease. Mov Disord. (2016) 31:861–81. 10.1002/mds.2666227193487)
Delgado-AlvaradoMGagoBNavalpotro-GomezIJiménez-UrbietaHRodriguez-OrozMC. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease. Mov Disord. (2016) 31:861–81. 10.1002/mds.2666227193487Delgado-AlvaradoMGagoBNavalpotro-GomezIJiménez-UrbietaHRodriguez-OrozMC. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease. Mov Disord. (2016) 31:861–81. 10.1002/mds.2666227193487, Delgado-AlvaradoMGagoBNavalpotro-GomezIJiménez-UrbietaHRodriguez-OrozMC. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease. Mov Disord. (2016) 31:861–81. 10.1002/mds.2666227193487
-
S. Bajaj, F. Krismer, J. Palma, G. Wenning, H. Kaufmann, W. Poewe, K. Seppi (2017)
Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysisPLoS ONE, 12
-
(HassanAParisiJEJosephsKA. Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia. Neurocase. (2012) 18:478–88. 10.1080/13554794.2011.62734522181323)
HassanAParisiJEJosephsKA. Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia. Neurocase. (2012) 18:478–88. 10.1080/13554794.2011.62734522181323HassanAParisiJEJosephsKA. Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia. Neurocase. (2012) 18:478–88. 10.1080/13554794.2011.62734522181323, HassanAParisiJEJosephsKA. Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia. Neurocase. (2012) 18:478–88. 10.1080/13554794.2011.62734522181323
-
(Santos-SantosMAMandelliMLBinneyRJOgarJWilsonSMHenryML Features of patients with Nonfluent/Agrammatic primary progressive aphasia with underlying progressive supranuclear palsy pathology or corticobasal degeneration. JAMA Neurol. (2016) 73:733–42. 10.1001/jamaneurol.2016.041227111692)
Santos-SantosMAMandelliMLBinneyRJOgarJWilsonSMHenryML Features of patients with Nonfluent/Agrammatic primary progressive aphasia with underlying progressive supranuclear palsy pathology or corticobasal degeneration. JAMA Neurol. (2016) 73:733–42. 10.1001/jamaneurol.2016.041227111692Santos-SantosMAMandelliMLBinneyRJOgarJWilsonSMHenryML Features of patients with Nonfluent/Agrammatic primary progressive aphasia with underlying progressive supranuclear palsy pathology or corticobasal degeneration. JAMA Neurol. (2016) 73:733–42. 10.1001/jamaneurol.2016.041227111692, Santos-SantosMAMandelliMLBinneyRJOgarJWilsonSMHenryML Features of patients with Nonfluent/Agrammatic primary progressive aphasia with underlying progressive supranuclear palsy pathology or corticobasal degeneration. JAMA Neurol. (2016) 73:733–42. 10.1001/jamaneurol.2016.041227111692
-
北尾 慎一郎 (2014)
Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies -
Du (2017)
Combined diffusion tensor imaging and apparent transverse relaxation rate differentiate Parkinson disease and Atypical ParkinsonismAJNR Am J Neuroradiol., 38
-
B. Heim, F. Krismer, Roberto Marzi, K. Seppi (2017)
Magnetic resonance imaging for the diagnosis of Parkinson’s diseaseJournal of Neural Transmission, 124
-
C. Davie, G. Barker, Christine Machado, David Miller, A. Lees (1997)
Proton magnetic resonance spectroscopy in steele‐richardson‐olszewski syndromeMovement Disorders, 12
-
(De MarziRSeppiKHöglBMüllerCScherflerCStefaniA. Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behavior disorder. Ann Neurol. (2016) 79:1026–30. 10.1002/ana.2464627016314)
De MarziRSeppiKHöglBMüllerCScherflerCStefaniA. Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behavior disorder. Ann Neurol. (2016) 79:1026–30. 10.1002/ana.2464627016314De MarziRSeppiKHöglBMüllerCScherflerCStefaniA. Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behavior disorder. Ann Neurol. (2016) 79:1026–30. 10.1002/ana.2464627016314, De MarziRSeppiKHöglBMüllerCScherflerCStefaniA. Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behavior disorder. Ann Neurol. (2016) 79:1026–30. 10.1002/ana.2464627016314
-
N. Focke, G. Helms, P. Pantel, S. Scheewe, Michael Knauth, C. Bachmann, J. Ebentheuer, P. Dechent, W. Paulus, C. Trenkwalder (2011)
Differentiation of Typical and Atypical Parkinson Syndromes by Quantitative MR ImagingAmerican Journal of Neuroradiology, 32
-
M. Morelli, G. Arabia, F. Novellino, M. Salsone, L. Giofrè, F. Condino, D. Messina, Aldo Quattrone (2011)
MRI measurements predict PSP in unclassifiable parkinsonismsNeurology, 77
-
(HeimBKrismerFSeppiK. Structural imaging in Atypical Parkinsonism. Int Rev Neurobiol. (2018) 142:67–148. 10.1016/bs.irn.2018.08.01030409261)
HeimBKrismerFSeppiK. Structural imaging in Atypical Parkinsonism. Int Rev Neurobiol. (2018) 142:67–148. 10.1016/bs.irn.2018.08.01030409261HeimBKrismerFSeppiK. Structural imaging in Atypical Parkinsonism. Int Rev Neurobiol. (2018) 142:67–148. 10.1016/bs.irn.2018.08.01030409261, HeimBKrismerFSeppiK. Structural imaging in Atypical Parkinsonism. Int Rev Neurobiol. (2018) 142:67–148. 10.1016/bs.irn.2018.08.01030409261
-
(HanY-HLeeJ-HKangB-MMunC-WBaikS-KShinY-I. Topographical differences of brain iron deposition between progressive supranuclear palsy and Parkinsonian variant multiple system atrophy. J Neurol Sci. (2013) 325:29–35. 10.1016/j.jns.2012.11.00923260321)
HanY-HLeeJ-HKangB-MMunC-WBaikS-KShinY-I. Topographical differences of brain iron deposition between progressive supranuclear palsy and Parkinsonian variant multiple system atrophy. J Neurol Sci. (2013) 325:29–35. 10.1016/j.jns.2012.11.00923260321HanY-HLeeJ-HKangB-MMunC-WBaikS-KShinY-I. Topographical differences of brain iron deposition between progressive supranuclear palsy and Parkinsonian variant multiple system atrophy. J Neurol Sci. (2013) 325:29–35. 10.1016/j.jns.2012.11.00923260321, HanY-HLeeJ-HKangB-MMunC-WBaikS-KShinY-I. Topographical differences of brain iron deposition between progressive supranuclear palsy and Parkinsonian variant multiple system atrophy. J Neurol Sci. (2013) 325:29–35. 10.1016/j.jns.2012.11.00923260321
-
J. Whitwell, Joseph Duffy, E. Strand, M. Machulda, M. Senjem, J. Gunter, K. Kantarci, S. Eggers, C. Jack, K. Josephs (2013)
Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsyEuropean Journal of Neurology, 20
-
(SurovaYNilssonMLättJLampinenBLindbergOHallS. Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy. Neuroradiology. (2015) 57:1079–91. 10.1007/s00234-015-1563-z26253801)
SurovaYNilssonMLättJLampinenBLindbergOHallS. Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy. Neuroradiology. (2015) 57:1079–91. 10.1007/s00234-015-1563-z26253801SurovaYNilssonMLättJLampinenBLindbergOHallS. Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy. Neuroradiology. (2015) 57:1079–91. 10.1007/s00234-015-1563-z26253801, SurovaYNilssonMLättJLampinenBLindbergOHallS. Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy. Neuroradiology. (2015) 57:1079–91. 10.1007/s00234-015-1563-z26253801
-
(RizzoGZanigniSDe BlasiRGrassoDMartinoDSavicaR. Brain MR contribution to the differential diagnosis of Parkinsonian syndromes: an update. Parkinsons Dis. (2016) 2016:2983638. 10.1155/2016/298363827774334)
RizzoGZanigniSDe BlasiRGrassoDMartinoDSavicaR. Brain MR contribution to the differential diagnosis of Parkinsonian syndromes: an update. Parkinsons Dis. (2016) 2016:2983638. 10.1155/2016/298363827774334RizzoGZanigniSDe BlasiRGrassoDMartinoDSavicaR. Brain MR contribution to the differential diagnosis of Parkinsonian syndromes: an update. Parkinsons Dis. (2016) 2016:2983638. 10.1155/2016/298363827774334, RizzoGZanigniSDe BlasiRGrassoDMartinoDSavicaR. Brain MR contribution to the differential diagnosis of Parkinsonian syndromes: an update. Parkinsons Dis. (2016) 2016:2983638. 10.1155/2016/298363827774334
-
S. Lehéricy, É. Bardinet, C. Poupon, M. Vidailhet, C. François (2014)
7 tesla magnetic resonance imaging: A closer look at substantia nigra anatomy in Parkinson's diseaseMovement Disorders, 29
-
(NicolettiGTononCLodiRCondinoFMannersDMalucelliE. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease. Mov Disord. (2008) 23:2370–6. 10.1002/mds.2227918816803)
NicolettiGTononCLodiRCondinoFMannersDMalucelliE. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease. Mov Disord. (2008) 23:2370–6. 10.1002/mds.2227918816803NicolettiGTononCLodiRCondinoFMannersDMalucelliE. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease. Mov Disord. (2008) 23:2370–6. 10.1002/mds.2227918816803, NicolettiGTononCLodiRCondinoFMannersDMalucelliE. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease. Mov Disord. (2008) 23:2370–6. 10.1002/mds.2227918816803
-
(NicolettiGLodiRCondinoFTononCFeraFMalucelliE. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain. (2006) 129:2679–87. 10.1093/brain/awl16616815875)
NicolettiGLodiRCondinoFTononCFeraFMalucelliE. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain. (2006) 129:2679–87. 10.1093/brain/awl16616815875NicolettiGLodiRCondinoFTononCFeraFMalucelliE. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain. (2006) 129:2679–87. 10.1093/brain/awl16616815875, NicolettiGLodiRCondinoFTononCFeraFMalucelliE. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain. (2006) 129:2679–87. 10.1093/brain/awl16616815875
-
A. Martin-Bastida, S. Pietracupa, P. Piccini (2017)
Neuromelanin in parkinsonian disorders: an updateInternational Journal of Neuroscience, 127
-
J. Whitwell, C. Jack, J. Parisi, J. Gunter, S. Weigand, B. Boeve, J. Ahlskog, R. Petersen, D. Dickson, K. Josephs (2013)
Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathologyEuropean Journal of Neurology, 20
-
(HeimBKrismerFde MarziRSeppiK. Magnetic resonance imaging for the diagnosis of Parkinson's disease. J Neural Transm (Vienna). (2017) 124:915–64. 10.1007/s00702-017-1717-828378231)
HeimBKrismerFde MarziRSeppiK. Magnetic resonance imaging for the diagnosis of Parkinson's disease. J Neural Transm (Vienna). (2017) 124:915–64. 10.1007/s00702-017-1717-828378231HeimBKrismerFde MarziRSeppiK. Magnetic resonance imaging for the diagnosis of Parkinson's disease. J Neural Transm (Vienna). (2017) 124:915–64. 10.1007/s00702-017-1717-828378231, HeimBKrismerFde MarziRSeppiK. Magnetic resonance imaging for the diagnosis of Parkinson's disease. J Neural Transm (Vienna). (2017) 124:915–64. 10.1007/s00702-017-1717-828378231
-
(GuanXXuanMGuQHuangPLiuCWangN. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping. NMR Biomed. (2017) 30:3489. 10.1002/nbm.348926853890)
GuanXXuanMGuQHuangPLiuCWangN. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping. NMR Biomed. (2017) 30:3489. 10.1002/nbm.348926853890GuanXXuanMGuQHuangPLiuCWangN. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping. NMR Biomed. (2017) 30:3489. 10.1002/nbm.348926853890, GuanXXuanMGuQHuangPLiuCWangN. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping. NMR Biomed. (2017) 30:3489. 10.1002/nbm.348926853890
-
Höglinger (2017)
Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteriaMov Disord., 32
-
(DeistungASchweserFReichenbachJR. Overview of quantitative susceptibility mapping. NMR Biomed. (2017) 30:3569. 10.1002/nbm.356927434134)
DeistungASchweserFReichenbachJR. Overview of quantitative susceptibility mapping. NMR Biomed. (2017) 30:3569. 10.1002/nbm.356927434134DeistungASchweserFReichenbachJR. Overview of quantitative susceptibility mapping. NMR Biomed. (2017) 30:3569. 10.1002/nbm.356927434134, DeistungASchweserFReichenbachJR. Overview of quantitative susceptibility mapping. NMR Biomed. (2017) 30:3569. 10.1002/nbm.356927434134
-
C. Guevara, Camilla Blain, Daniel Stahl, D. Lythgoe, P. Leigh, Gareth Barker (2010)
Quantitative magnetic resonance spectroscopic imaging in Parkinson’s disease, progressive supranuclear palsy and multiple system atrophyEuropean Journal of Neurology, 17
-
(Del TrediciKBraakH. Review: sporadic Parkinson's disease: development and distribution of α-synuclein pathology. Neuropathol Appl Neurobiol. (2016) 42:33–50. 10.1111/nan.1229826662475)
Del TrediciKBraakH. Review: sporadic Parkinson's disease: development and distribution of α-synuclein pathology. Neuropathol Appl Neurobiol. (2016) 42:33–50. 10.1111/nan.1229826662475Del TrediciKBraakH. Review: sporadic Parkinson's disease: development and distribution of α-synuclein pathology. Neuropathol Appl Neurobiol. (2016) 42:33–50. 10.1111/nan.1229826662475, Del TrediciKBraakH. Review: sporadic Parkinson's disease: development and distribution of α-synuclein pathology. Neuropathol Appl Neurobiol. (2016) 42:33–50. 10.1111/nan.1229826662475
-
(WorkerABlainCJaroszJChaudhuriKRBarkerGJWilliamsSCR. Cortical thickness, surface area and volume measures in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. PLoS ONE. (2014) 9:e114167. 10.1371/journal.pone.011416725463618)
WorkerABlainCJaroszJChaudhuriKRBarkerGJWilliamsSCR. Cortical thickness, surface area and volume measures in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. PLoS ONE. (2014) 9:e114167. 10.1371/journal.pone.011416725463618WorkerABlainCJaroszJChaudhuriKRBarkerGJWilliamsSCR. Cortical thickness, surface area and volume measures in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. PLoS ONE. (2014) 9:e114167. 10.1371/journal.pone.011416725463618, WorkerABlainCJaroszJChaudhuriKRBarkerGJWilliamsSCR. Cortical thickness, surface area and volume measures in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. PLoS ONE. (2014) 9:e114167. 10.1371/journal.pone.011416725463618
-
M. Sasaki, Eri Shibata, K. Tohyama, J. Takahashi, K. Otsuka, K. Tsuchiya, Satoshi Takahashi, S. Ehara, Y. Terayama, A. Sakai (2006)
Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's diseaseNeuroReport, 17
-
Hirohisa Watanabe, Yufuko Saito, S. Terao, T. Ando, T. Kachi, E. Mukai, I. Aiba, Y. Abe, A. Tamakoshi, M. Doyu, M. Hirayama, G. Sobue (2002)
Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients.Brain : a journal of neurology, 125 Pt 5
-
F. Federico, I. Simone, V. Lucivero, M. Mari, P. Giannini, G. Iliceto, D. Mezzapesa, P. Lamberti (1997)
Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.Journal of Neurology, Neurosurgery & Psychiatry, 62
-
Christoph Mueller, A. Hussl, F. Krismer, B. Heim, P. Mahlknecht, M. Nocker, C. Scherfler, K. Mair, R. Esterhammer, M. Schocke, G. Wenning, W. Poewe, K. Seppi (2018)
The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism.Parkinsonism & related disorders, 54
-
(ScherflerCGöbelGMüllerCNockerMWenningGKSchockeM. Diagnostic potential of automated subcortical volume segmentation in atypical Parkinsonism. Neurology. (2016) 86:1242–9. 10.1212/WNL.000000000000251826935895)
ScherflerCGöbelGMüllerCNockerMWenningGKSchockeM. Diagnostic potential of automated subcortical volume segmentation in atypical Parkinsonism. Neurology. (2016) 86:1242–9. 10.1212/WNL.000000000000251826935895ScherflerCGöbelGMüllerCNockerMWenningGKSchockeM. Diagnostic potential of automated subcortical volume segmentation in atypical Parkinsonism. Neurology. (2016) 86:1242–9. 10.1212/WNL.000000000000251826935895, ScherflerCGöbelGMüllerCNockerMWenningGKSchockeM. Diagnostic potential of automated subcortical volume segmentation in atypical Parkinsonism. Neurology. (2016) 86:1242–9. 10.1212/WNL.000000000000251826935895
- Publisher
- Unpaywall
- ISSN
- 1664-2295
- DOI
- 10.3389/fneur.2020.00665
- Publisher site
- See Article on Publisher Site
Abstract
Journal
Frontiers in Neurology – Unpaywall
Published: Jul 17, 2020